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Abstract
A blocbeolcal investigation into aspects of the neuro active amino 
acid receptor c<»iplexes in the insect nervous system.
Peter Baines
Biochemical investigations were undertaken to study the glutamate 
(L-glu) and ¿T-aminobutyric acid (GABA) receptors in the central 
nervous system (CNS) of the American cockroach, Periplaneta 
americana» The aim was to provide a simple, quick and cost effective 
method of screening new chemical entities as potential insecticides 
acting on these systems, and to provide structure activity 
information once a series had been suggested as active in these 
systems.
Using radioligand binding techniques, specific binding sites were 
revealed for both these amino acids in a Pp preparation from whole 
CNS material. The receptor for L-glu showed similar receptor binding 
properties to excitatory amino acid receptors in the mammalian CNS, 
having a K. of 1.80x 10” 'm  and a B of 10.6fmoles/pg. Despite the 
similarities to the mammalian rece^or, there were subtle differences 
in the pharmacological profile which may be exploitable in the design 
of safe insecticides. This work represents the first piece of 
evidence for the presence of L-glu as a transmitter in the CNS of 
insects, as opposed to the peripheral nervous system, where its role 
as a transmitter is now well accepted.
The receptor for GABA was studied in more detail. Specific binding 
of this ligagd was found, but the equilibrium constants obtained 
(K. 1.79x10” M, 16.1 fmoles/pg) showed the receptor to be less
avid than that normally found with a GABA neuro-receptor site.
Reasons why this may be so are discussed. However, the 
pharmacological profile obtained using the potent GABA-mimetic, 
muscimol, suggest that this site is pertinent to the role of GABA as 
a neurotransmitter in the insect CNS, and that this receptor 
resembles the GABA^ receptor described in mammals. However, 
differences in the exact profile of the mammalian and insect 
receptors again suggest that this system may provide a site of action 
for a new and safe series of insecticides.
Other areas of the biochemistry of the GABA receptor were 
investigated, and the results are discussed. Such positive results 
as were obtained confirm the identification of this receptor as 
relevant to the role of GABA as a neurotransmitter.
Although relevant receptors for both L-glu and GABA were 
demonstrated, it was not possible to use these as routine screens for 
the testing of potential new insecticides because of the large number 
of replicates needed to overcome the variations inherent in the 
technique.
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1.1 The Insect nervous system.
The insect nervous system provides a communications network through 
which sensory information generated by the activation of peripheral 
sensory receptor cells can be rapidly passed to the central nervous 
system (CNS), where it is processed and relayed to the appropriate 
effector cells which will react accordingly. The afferent sensory 
neurons with their associated sensory receptor cells and the efferent 
motor and effector cells make up the insect peripheral nervous 
system. Communication between the afferent and the efferent pathways 
is mediated by the interneurons in the ganglia of the CNS.
The insect nervous system is bilaterally symmetrical and segmented.
A schematic diagram of the structure of the CNS of the American 
cockroach, Periplaneta americana, is given in Figure 1.1. The CNS 
consists of a dorsal anterior brain and a central nerve cord. The 
segmentation of the cerebral ganglia is no longer apparent, as the 
segmental boundaries have become lost in the evolutionary process. 
Within the cerebral nerve mass there is a supraoesophageal ganglion 
(the brain proper) connected to the suboesophageal ganglion and the 
ganglia of the stomatogastric nervous system. This is then connected 
to the central nerve cord, which consists of three thoracic and six 
abdominal ganglia. These ganglia are double laterally fused 
structures joined to the others by pairs of interganglionic 
connectives. In higher orders of insects, such as the dipteran 
flies, these ganglia have become fused into one nerve mass located in 
the thorax. The peripheral nervous system arises from the CNS and 
consists of the neuromuscular, the sensory and the stomatogastric 
systems.
The basic element of the nervous system is the neuron. This 
specialised cell consists of the following elements (Figure 1.2):
a) the cell body or soma containing the nucleus;
b) the dendritic tree, a structure which is often highly branched
and through which is received the afferent nervous input;
c) the axon, which acts as the efferent component of the neuron
through which the nervous signal is prop a gated for 
transmission to other neurons or effector cells;
-  2 -
Figure 1.1
The nervous system of the American cockroach, P.americana.
This diagram shows the segmental nature of the cockroach CNS. The 
cerebral ganglia are a fusion of what were once separate ganglia. 
However, in the cockroach, the ganglia of the central nerve cord 
remain separate, consisting of three thoracic and six abdominal 
ganglia. In species such as the dipteran flies, these ganglia have 
also become fused into a second nerve mass.
- 3 -
Figure 1.2
A schematic diagram of a simple neuron.
This diagram shows a simple neuron, as described in the text. The 
following features are labelled;
C - cell body
D - dendritic tree
A - axon
S - synapse
-  A -
d) the synapse, which is the area where contact is made between the 
various elements of the nervous system, which consists of a 
specialised area of closely opposed presynaptic and 
postsynaptic membranes.
Contact between neurons within the insect nervous system may be 
axo-axonic, axo-dendritic, dendro-axonic or dendro-dendritic. Unlike 
vertebrates, all insect neuronal cell bodies are located on the 
periphery of the ganglia.
1 .1.1 The chemical synapse.
The chemically mediated synapse in the insect has a synaptic cleft of 
between 5 and 25nm separating the pre- and postsynaptic elements 
(Osborne:1970). Within the CNS these elements are characterised by 
electron-dense thickening of the opposed membranes (Osborne:1966).
The electron dense material on the cytoplasmic surface of the 
postsynaptic membrane is of a uniform nature, whilst that on the 
cytoplasmic surface of the presynaptic membrane is formed into 
projections or rod like structures. Within the presynaptic terminal 
are vesicles which are believed to contain the neurotransmitter.
These synaptic vesicles are often attached to the presynaptic 
specialisations by filamentous material which may facilitate 
transmitter release (Osborne:1975). The presynaptic terminals also 
contain large numbers of mitochondria, microtubles and endoplasmic 
reticulum, indicative of a high metabolic turnover. Many of these 
structures cam be seen in the sub-cellular entities known as 
synaptoscMnes. These 'pinched -off nerve terminals are obtained by 
tissue fractionation and are often used in biochemical studies of the 
nervous system. As well as the characteristic elements of the 
pre-synaptic terminal, they often contain the membranes of the 
post-synaptic specialisation (Figure 1.3). The structure of the 
nerve-muscle synapse is very similar.
When the neuron receives the appropriate stimulus, an action 
potential is sent along the axon to the terminal. This consists of a 
wave of depolarisation mediated by transient changes in the axonic 
membrane's permeability to sodium and potassium ions. When this 
arrives at the nerve terminal, large numbers of the pre-synaptic
- 5 -


vesicles collide and merge with the pre-synaptic membrane in a 
calcium dependent manner, causing the release of their contents into 
the synaptic cleft. The post-synaptic response is produced when the 
transmitter substance binds to receptors on the post-synaptic 
membrane. This in turn activates ionophores causing transient 
changes in the postsynaptic membrane's ion permeability. The 
response may be excitatory, in which case the postsynaptic cell is 
depolarized, usually by the influx of sodium ions, or inhibitory.
This latter response is caused by the influx of chloride ions, which
may or may not cause a hyperpolarisation of the cell, as the resting
potential in insects is usually close to the chloride reversal
potential (Piek;1975).
Even in the absence of a depolarising current small numbers of 
neurotransmitter vesicles are thought to interact with the 
pre-synaptic membrane, the release of the transmitter contained 
within them producing small, quantum responses in the post-synaptic 
cell. Such responses are termed miniature endplate potentials 
(mineps) and are the main evidence for the quantal nature of 
neurotransmitter release (Fatt and Katz;1952).
1.1.2 Neural control of the insect muscle.
The organisation and control of the insect skeletal muscle has been 
described by Hoyle (1975). Insect muscles are small and consist of 
only a few muscle units. For this reason, control of the degree of 
contraction cannot be achieved in the same manner as is found in 
vertebrates. In vertebrates, control is achieved by the 
"all-or-nothing” contraction of a small number of motor units, each 
being only a small part of a whole muscle. To produce a more 
powerful response, extra muscle units are recruited. This is in 
contrast to the situation in the insect, where a graded mechanical 
response is achieved by multi-terminal innervation of each unit by 
excitatory and inhibitory axons, the tension produced in these 
muscles depending upon the balance of these axons' activities.
- 7 -
Excitatory axons may be termed "fast” or "slow" according to the 
response they induce in the post-synaptic muscle cell (Hoyle:1955). 
Fast axons produce a large post-synaptic potential upon which an 
electrically excited ccmiponent is superimposed, giving a brief but 
powerful twitch of the muscle which decreases in strength with the 
distance from the endplate. Increasing the rate of stimulation 
causes fusion of the contractions giving a smooth, sustained muscle 
contraction at about 20 stimuli per second. Slow axons produce a 
small depolarisation of the muscle cell membrane, producing very 
little mechanical response. Repetitive stimulation causes 
facilitation of this small postsynaptic potential, increasing the 
velocity and extent of the muscle contraction. It has been proposed 
that these two types of excitatory response are mediated by two 
different transmitters, but this is far from proven (Irving and 
Miller:1980).
1.2 The Insect nervous system as a site for pesticide action.
The insect nervous system is not as well shielded as that of 
vertebrates. The vertebrate CNS is well screened from the 
environment. Not only is part of it segregated by the so-called 
'blood-brain barrier', but it is bathed by a specialised fluid (the 
cerebro spinal fluid) which is not accessible to environmentally 
introduced contaminants. The insect system is not as well protected. 
Although it has a partial 'blood -brain barrier' (Lane:197A; 
Treherne:197A), it is not as effective and lacks the support of a 
separate bathing fluid. This ready accessibility from the outside 
makes the insect nervous system a prime target for insecticides.
Many groups of insecticides already in use act upon this system.
Three major examples are given below:
a) Organophosphates - Acetyl choline acts as an excitatory
transmitter at both the central and peripheral levels in 
insects. It is normally removed from the synaptic cleft by 
the action of the enzyme acetyl choline esterase. Compounds 
such as Malathion (LIV) and Diazinon (LV) are now known to 
act by inhibiting this enzyme. The enzyme forms a suicide 
complex with this group of insecticides, causing increased
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nlevels of acetyl choline in the synapase, leading to 
hyperactivity and death in the insect poisoned with these 
compounds.
b) Pyrethroids and DDT - Pyrethroids, such as permethrin (LVD, and
• DDT (LVII) are known to act by opening the sodium channel, 
causing an influx of sodium ions and thus depolarization of 
the nerve. This will lead to excitability in the insect and 
in turn to death.
c) Cyclodienes and Lindane - Whilst the two groups of compounds
given above lead to death through overstimulation of 
excitatory responses, the group of compounds which include 
cyclodienes, such as dieldrin (XLIV), and y-BHC (or 
Lindane:XLV) cause death by perturbing the effects of the 
inhibitory control of the nervous system. These compounds 
act by blocking the chloride channel, once more causing 
hyperexcitability and death.
Through prolonged use in the field, insects have developed resistance 
mechanisms to all of these groups of compounds. That is to say that 
the amount of insecticide required to achieve a desired level of 
control has increased. In extreme cases, the resistance may be such 
that control can no longer be achieved. Even if this is not the 
case, the increased level of insecticide required to obtain the 
desired level of control may be such that that it is no longer 
cost-effective. Such resistance can broadly be of two sorts. In 
one, the insecticide is prevented from reaching the target site.
This form of resistance is commonly caused by an increase in the 
ability of the insect to metabolise the toxic ccxnpound. This form of 
resistance can often be overcome quite simply by the use of so-called 
synergistic compounds. These are compounds of low intrinsic activity 
which prevent the degradation of the main insecticide by the 
inhibition of the metabolising enzymes. Such a compound is piperonyl 
butoxide (LVIII), frequently used to enhance the activity of the 
pyrethroid insecticides. The second type of resistance involves a 
change in the target site itself. This is more difficult to overcome 
and can have additional problems in that it can render other classes 
of insecticides working through the same mechanism ineffective. When
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this occurs, the classes of insecticides are said to be 
cross-resistant.
Such target site resistance has developed for both the pyrethroid and 
the cyclodiene insecticides. The mode of action and the mechanism of 
resistance for the cyclodiene insecticides has been reviewed by 
Matsumura (1985), who has shown in previous work mentioned in this 
review that the resistance is caused by an alteration at the site on 
the chloride channel which binds pieròtoxinin (PTXrXLII). This 
alteration seems to confer resistance to many of the compounds which 
bind at this site, thus dieldrin, lindane and PTX all have lower 
toxicity towards those insect strains which exhibit this type of 
resistance. The resistance mechanisms to the pyrethroids have been 
studied for many years (Tsukamoto et al.;1965). They are known as 
kdr (knock down resistance) and skdr (super knock down resistance), 
which conféré levels of resistance of some 10 and 100 fold to 
permethrin respectively. These are caused by genetic modifications 
to the sodium channel and were initially brought about through the 
use of DDT, an insecticide which acts at the same site as the 
pyrethroids (Osborne and Hart:1979).
With such problems developing in the current series of insecticides 
and the danger of cross-resistance occuring in new series which use 
the same modes of action as pesticides currently in use, it would 
seem prudent to search for new insecticides which act on an area of 
the nervous system not yet exploited as a site of insecticide 
activity. Such areas may be provided by the receptor sites for the 
closely related amino acids L-glumatic acid (L-glu:I) and 
¿'-aminobutyric acid (GABArXVII).
1.3 Criteria for the identification of neurotransmitters.
Werman (1966) laid down six criteria for the identification of a 
compound as a neurotransmitter. These were:
i) that the compound should be present in the neurotransmitter 
pool.
ii) that the compound be released by neural stimulation from the 
pre-synaptic terminal in sufficient amounts.
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iii) that the compound have an identical action at the post-synaptic 
membrane to the natural transmitter.
iv) that the compound interacts with the post-synaptic membrane in 
the same way as the natural transmitter.
v) that synthetic and degradative enzymes be present 
pre-synaptically.
vi) that there be a mechanism for the removal of the compound from 
the synaptic cleft in order to terminate the action of the 
compound.
Ideally all these criteria should be fulfilled before a compound can 
be classed as a neurotransmitter.
1.3.1 General introduction to the use of ligand binding 
experiments.
Many of the criteria outlined above can only be studied adequately by 
the use of electrophysiological techniques. However, biochemical 
studies do have a significant role to play as well and the use of 
radiolabelled ligands to study the biochemistry of receptors of 
pharmacological and physiological interest is now well established. 
Care must be taken to ensure that the ligand binding that is being 
studied is as expected; that is to say that it is not Just an 
experimental artefact caused either by the equipment used, or by an 
interaction with parts of the biological material other than that 
supposed to be under investigation. Even after many years experience 
with this type of experiment the problems of equipment artefacts are 
still with us. Thus, although Cuatrecasas and Hollenberg (1976) 
reviewed the problems they had encountered with the 'specific' 
non-receptor binding of various peptide hormones to glassware and 
membrane filters ten years ago, such problems still bedevil 
biochemists today (eg. the interesting -receptor in glass filters 
reported by Bielkiewicz and Cook:1985). The field of receptor 
studies is also well strewn with examples of non-pharmacological 
receptors (eg. the example of Guth:1982), or receptors that were not 
what they at first appeared (eg. the supposed binding of [^H]-kainic 
acid to the central receptors for L-glu). Various sets of criteria 
have been laid down to try to avoid such mistakes. In his 1985 
review, Burt laid down the following basic criteria:
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a) Saturability - although this is sometimes seen as a sufficient
criterion, it is only the beginning.
b) Kinetics - the binding of the neurotransmitters themselves should
be readily reversible, as should that of any other ligands 
that are known to be pharmacologically reversible. To help 
to confirm this, the association and dissociation rates 
should be studied and their ratio should be found to be close 
to the experimental equilibrium constant.
c) Distribution - subcellular, tissue, regional and species
distribution should follow the known pharmacological 
distribution of the receptor under study.
d) Pharmacology - the binding of ligands to the site under study 
should follow the known pharamacological profile in the areas 
of stereospecificity, agonist and antagonist compounds. With 
many compounds it is crucial to choose the correct parameters 
as they bind to more than one receptor. Thus lysergic acid 
diethylamide binds to both dopamine and serotonin receptors 
in a stereospecific manner; when this is used as a 
radioligand, the two sites can be distinguished by the 
careful selection of the displacing agent.
It is rare that any study will match all of these criteria. Even if 
that were possible, there would still be room for doubt until the 
receptor had been totally solublised and reconstructed, as has been 
achieved with the acetylcholine receptor from the electric fish, 
Torpedo marmorata. However, such criteria should be borne in mind 
when using radioligands to try to study pharamacologically 
interesting receptors.
In studying the biochemistry of receptors using ligand binding 
techniques, mention is frequently made of three classes of binding 
and three basic types of plot. The types of binding are the 
specific, saturable or displaceable binding; the non-specific or
non-displaceable binding and the total binding. These are defined as 
follows:
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a) The specific binding is considered as that component of the
radioligand binding which is actually bound to the receptor 
under consideration. As there are only a finite number of 
these receptors this binding can easily be diluted out by 
adding excess cold ligand or specific displacer - a compound 
that is a potent agonist or antagonist of the in vivo 
pharmacological action. The choice of the compound used to 
define the specific binding must be made with care. Thus PTX 
(XLII) is often considered to be a specific antagonist of the 
action of GABA (XVII), which is an opener of chloride 
channels. However, receptor binding studies soon showed that 
these two compounds act through different receptors - the 
binding of GABA to its receptor promotes the opening of the 
chloride channel, which action is antagonised by PTX because 
this compound blocks the chloride ionophore itself.
I b) The non-specific binding is that component of the binding that 
cannot be diluted out by an excess of the appropriate 
displacer. This component is considered to be caused by such 
non-receptor phenomena as the partitioning of the radioligand 
into the lipid environment of the membrane preparation, the 
association of the ligand with non-specific proteins and the 
interaction of the ligand with the equipment used in the 
experimental protocol.
c) The total binding is the sura of these two.
In practice, the specific binding is arrived at by the difference 
between the total binding - measured when no displacer is present, 
and the non-specific binding - measured in the presence of excess 
displacer.
The three plots used are the semi-log, the Scatchard and the Hill 
plots. They are as follows:
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i) The semi-log plot shows the percentage of the specific sites 
occupied as a function of the log of the displacer concentration.
ii) The Scatchard plot is the graph of the ratio of the concentration
of the amount of ligand specifically bound to the receptor over
the concentration of the free ligand against the concentration of
the free ligand. As such, it is analogous to the Eadie plot used
in enzyme studies. A straight line is indicative of a single
population of non-cooperative receptors. In such a case it is
easy to derive the equilibrium dissociation constant (K^) and thed
number of receptors present (B ) from the slope of the line andluoX
its intercept on the x—axis. It can also be used to study the 
potency and class of inhibitors of the interaction between the 
receptor and the radioligand.
iii) The Hill plot is the graph of the log of the ratio of the 
concentration of the number of receptor sites bound to the ligand 
over the total concentration of receptor sites less the 
concentration of those bound against the log of the concentration 
of the free ligand. A linear relationship for this plot will 
yield both the number of ligand molecules bound to each receptor 
site (from the slope) and the of the receptor-ligand complex 
(from the intercept on the x-axis). If this plot gives a 
non-linear relationship, then the limiting slope of the curve 
yields the number of ligand molecules bound to each receptor 
molecule.
The referred to in the descriptions above is an inverse measure of 
the affinity of the ligand for its receptor. Thus a low value for 
the indicates that the ligand has a high affinity for the receptor 
(ie. it is a good ligand for that receptor), whilst a high value 
indicates that the ligand has a low affinity for the receptor (ie. 
that it is a poor ligand for the receptor). The curves described 
above are treated in more detail in the Results section, where the 
mathematical proof of the relationships is also derived from the law 
of mass action (See Sections 3.2.1 and 3.2.2).
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1 .A The role of L-glu as a neuro transmit ter in the Insect
Neurotransmitter roles for both L-glu (I) and GABA (XVII) had been 
proposed in the 1950's because of their action on arthropod (Van 
Harreveld and Mendelson: 1959) and mammalian (Florey: 195A; Hayashi: 
195A) nervous systems. However, this role for L-glu was not accepted 
for many years because of its ubiquitous nature and central position 
in intermediate metabolism. Thus, in homogenates of the muscle from 
the locust Schistocerca gregaria, the content of L-glu was found to 
be 2277pg/g tissue (Briley et al.:1982). whilst its level in the 
haemolymph of various insects lay between 0.1mM and 2.0mM (Wright:
198A). Such levels were higher than those required to activate the 
appropriate channels on the insect muscle, whilst the metabolic role 
of this amino-acid can be seen from Figure 1.A, which schematically 
outlines the involvement of the two amino acids in this area. As can 
be seen, L-glu not only takes part in the synthesis of proteins, but 
is also the precursor for other amino-acids and has a vital role to 
play in the metabolism of ammonia. However, the evidence for the 
transmitter role of L-glu soon became overwhelming.
The electrophysiological evidence for the role of 
L-glu as a neurotransmitter at the arthropod neuromuscular junction.
L-glu was shown to be excitatory in both mammals (Hayashi: 195A;
Curtis and Watkins: 1960a) and Crustacea (Van Harreveld and 
Mendelson: 1959) many years ago, but was not initially accepted as a 
putative neurotransmitter. However, the evidence continued to mount, 
until L-glu is now accepted as the major excitatory transmitter at 
the arthropod neuromuscular junction (nmj). There have now been many 
reviews on the subject (e.g. Lunt: 1975; Usherwood: 1981). In his 
1981 review, Usherwood could make the following statement concerning 
the evidence for L-glu as the transmitter at the arthropod nmj:
1 • Identity of action: The postsynaptic receptors gate action of 
selective ionophores, the reversal potential of the 
synaptic current and the L-glu current having the same 
value. The mean conductance and lifetime of these 
ionophores is also identical whether they are gated through 
the action of L-glu or the natural transmitter....
- 15 -
CD
Figure 1.A
The metabolic roles of L>glu and GABA
This diagram shows schematically the central importance of L-glu (I) 
and GABA (XVII) in intermediate metabolism. The diagram is based 
upon that given in Carolei et al. (1978).
The enzymes mentioned in this thesis are:
E.C. NUMBER I.U.B. NAME TRIVIAL NAME
A A.1.1.15 L-glutamate 1-carboxy-lyase glutamate decarboxylase
B 2.6.1.19 A-aminobutyrate: /-aminobutyric acid
2-oxoglutarate aminotransferase transaminase
C 1.2.1.16 succinic semialdehyde-NAD"^ succinic semialdehyde
oxidoreductase dehydrogenase
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2. Release from the nerve terminal: L-glu is released from resting
locust nerve-muscle preparations in small quantities and in 
larger quantities... from stimulated preparations...
3. Inactivation of transmitter: High-affinity uptake of L-glu into
nerve terminals has been demonstrated at synapses on some 
insect muscles, but available physiological data suggest 
that removal of transmitter from the cleft is 
diffusional....
A. Precursors and synthesizing enzymes: Although enzymes and 
precursors for the syntheses of L-glu have not been 
demonstrated in insect motor nerve terminals, given the 
ubiquitous distribution of this amino acid their presence 
at these sites seems highly likely.
5. Presynaptic pharmacology: It could be argued that the presence of
presynaptic receptors for L-glu at locust excitatory 
nerve-muscle junctions supports the contention that this 
compound is the transmitter at these sites...
6 . Extrajunctional receptors:....  Extrajunctional receptors on
locust leg muscle comprise topographically heterogeneous 
populations of two receptor types; D-receptors which are 
similar pharmacologically to the junctional receptors found 
postsynaptically at excitatory junctions and H-receptors 
which have distinctive pharmacology and gate Cl'ionophores.
7. Denervation supersensitivity: When locust muscle is denervated
there is a significant increase in the sensitivity of the 
extrajunctional membrane to L-glu due to an increase in the 
population density of D-receptors (not H-receptors).....
On the basis of the evidence presented in 1-7 above, one is compelled 
to accept the conclusion that L-glu is the transmitter at the insect 
excitatory nerve-muscle junction".
However, there are still some observations that cast doubt upon this 
hypothesis. These were pointed out by Florey and Rathmayer (1981) 
and include the following:
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i) In low medium the effect of applied L-glu is reduced;
not so the effect of the natural transmitter.
ii) Diltiazem (LIX) increases the action of the natural transmitter 
but depresses the effect of applied L-glu.
iii) Concanavaline A prevents the desensitization to L-glu but 
enhances the depressant effect of L-glu on the amplitude of the 
excitatory post synaptic potential (epsp).
iv) bath-applied L-glu often causes a decrease of membrane 
conductance, in contrast to the natural transmitter which 
increases membrane conductance.
Some of these contradictions may be explained by the presence in the 
arthropod of multiple types of L-glu receptor, as detailed below.
1.A.2 Multiple receptor types from L-glu in the insect 
nerve-muscle systems and the mammalian CNS.
Electrophysiological investigation of the insect nerve-muscle system 
has suggested the existence of five receptors for L-glu. This work 
has been reviewed by Usherwood (1980) and Walker et al. (1980).
Three of these receptors are found at the nmj. Using the extensor 
tibia muscle of the locust S.gregaria, these can be classed by their 
preferred conformation for the L-glu molecule (Oration et al.: 1979)» 
They all gate Na^,K^ and Ca and are as follows:
a) This receptor prefers L-glu in its fully folded conformation, a 
conformation which leaves that compound similar in shape to 
L-aspartic acid (II), hence this receptor is classed as L-aspartic 
acid preferring.
b) This receptor prefers L-glu in its fully extended conformation and 
thus it responds to ibotenic acid (XLV) and is classed as ibotenic 
acid preferring.
c) The final receptor prefers L-glu in a partially folded 
conformation, being activated by neither L-aspartic acid nor 
ibotenic acid.
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In studies on the extensor tibia preparation it is the final type of 
receptor that accounts for the majority of those present. Types (a) 
and (b) account for only some 15-20% each and their exact function in 
the in vivo role of L-glu as the transmitter at the insect nmj is 
unknown.
There are also two types of extrajuctional receptors. The 
D-receptors (for depolarising) seem to gate the same ions as the 
junctional receptors described above. The exact pharmacology of 
these receptors is unknown and they may turn out to be heterogeneous 
in the same way as the junctional receptors. The second class of 
extrajunctional receptors is quite distinct. These are the 
H-receptors (for hyperpolarising) and they are found to gate Cl” ions 
and are sensitive to ibotenic acid. Thus on different areas in the 
same preparation, ibotenic acid elicits both depolarising and 
hyperpolarising activity.
Although there are no reports of the electrophysiological 
demonstration of L-glu receptors in the CNS of insects, it has been 
found to play a role in other arthropods. Thus Walker et al. (1981) 
failed to find any response to L-glu in the CNS of the cockroach, 
P.americana whilst finding an excitatory response in crab, Limulus
t
polyphemus.
The presence of three types of excitatory amino acid receptor at the 
nmj parellels the situation in the mammalian CNS. Here three 
receptors are also found for the excitatory amino acids, although 
they have a different pharmacology to those in the insect. The 
electrophysiological work on the mammalian system has been mainly 
undertaken using the cat spinal neurons. This work has been reviewed 
by Watkins et at. (1981) and Fagg (1985).
■M
The three classes of mammalian receptors are differentiated on their 
response to the antagonists L-glutamic acid diethyl ester (V) and 
2-amino-5-phosphonovaleric acid (2APV:VII). The latter compound is 
an antagonist of the first class of such receptors. 2APV antagonises 
the action of the neuroexcitatory compound N-methyl-D-aspartic acid 
(NMDAtIV). These responses are also inhibited by raised (20mM) 
levels of the divalent ion Mg^ '*’. The actions of the two isomers of
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2 ,A-piperidine dicarboxylic acid (IX) suggest that L-glu interacts 
with this receptor in a partially folded or aspartic acid-like 
manner. Thus the trans isomer is quite active, in contrast to the 
cis isomer which shows little or no activity. Work on the dorsal 
root evoked synaptic excitation of frog motorneurons suggests that 
these receptors play the major part in L-glu mediated 
neurotransmission.
In the mammal, the second class of excitatory amino acid receptors 
are those activated by the extended analogue of L-glu, quisqualic 
acid (XII). These receptors are antagonised by L-glutamic acid 
diethyl ester, but not by 2APV. They are also insensitive to the 
presence of Mg ions.
The final class of mammalian excitatory amino acid receptors are 
activated by kainic acid (XIV). These receptors are not antagonised 
by either of the two compounds mentioned above and may not be 
activated by L-glu at all.
Thus there would appear to be differences in the major receptors 
responsible for the excitatory action of L-glu in insects and 
mammals, a fact which may be able to be exploited for the development 
of specific insecticides.
1.A.3 The radioligand receptor binding evidence for the 
identification of L-glu as an excitatory neurotransmitter.
The amount of material obtainable for radioligand binding studies in 
the insect is limited. Because of the small size of test subjects, 
harvesting sufficient quantities of material can take considerable 
time, and even with care the product will be of questionable quality. 
Thus the favoured method of obtaining CNS material from flies is to 
sieve the insects with solid CO2 and use the heads as a crude source. 
However, this will not only contain CNS material, but also optic 
pigments, muscles and other contaminants. Obtaining purer 
preparations in sufficient quantities takes much longer than this 
method. Because of these difficulties much of our knowledge of the 
biochemistry of the L-glu receptor comes from studies on preparations 
from mammalian tissue-usually the rat brain.
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Early work on the binding of radiolabelled L-glu to its putative 
neuroreceptor was carried out using L-[^^C]-glu. With this ligand, 
Roberts (197A) and Michaelis et al« (197A) showed the presence of the 
specific binding of L-glu in membranes derived from the rat brain, 
whilst De Robertis eind Fiszer de Plazas (1976) showed similar results 
for a chloroform/methanol proteolipid extract from the same source. 
Further study was hampered by the high concentration of the
1Aradioligand needed because of the low specific activity of the C 
label. This was overcome with the arrival of tritium labelled L-glu, 
a label capable of giving a much higher specific activity. Thus in 
their 1981 review, Roberts and Sharif were able to list a wide range 
of compounds with their ability to displace the specific component of 
the L-glu membrane binding.
In this early work there were differences between the receptor types 
demonstrated biochemically and electrophysiologically. Thus the 
radioligand studies suggested that there was only one class of L-glu 
neuroreceptor, as opposed to the three types demonstrated by the use 
of electrophysiological techniques. The L-glu specifically bound at 
this site could be readily displaced by quisqualic acid, but neither 
NMDA nor kainic acid showed any such ability (Roberts and Sharif: 
1981).
However, with improved techniques, it is now possible to demonstrate 
up to four types of L-glu receptor in membranes derived from rat 
brains. Three of these are similar to those described in the 
electrophysiological studies. Radiolabelled L-glu proved to be a 
non-specific ligand, being displaced both by 2APV (the NMDA 
antagonist) and y-amino-3-hydroxy-5-methyl-isoxazole-A-propionic 
acid (AMPAtXVI; a new and specific agonist at the quisqualic acid 
site; Honoré et al.t 1981b) from membrane preparations. When these 
two compounds are used to displace radiolabelled L-glu from 
autoradiographs of thin tissue slices, they are found to do so from 
different areas of the brain - further indicating that they represent 
different receptor types. As expected, kainic acid is found to be a 
poor displacer of bound L-glu. This area of work has been reviewed 
by Fagg in his 1985 paper.
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The fourth type of receptor is one not described above. These 
receptors are revealed by the addition of 2.5mM CaCl^. The addition 
of this compound increases the number of L-glu binding sites by some 
three fold. This increase is antagonised by 2-amino-A- 
phosphonobutyric acid (APBrVI). The exact purpose of these receptors 
is uncertain (Fagg et al.;1982).
1.A.A Radioligand binding studies using labelled L-glu with 
tissue derived from the insect muscle.
Despite the paucity of material, some studies into the binding of 
L-glu to insect tissue have been undertaken. Early on in the study 
of radioligand binding of L-glu to its postsynaptic receptor in 
mammalian CNS there was a claim to have discovered a proteolipid 
receptor for the amino acid using the locust muscle as a starting 
point (Lunt:1973). However, this receptor preparation did not prove 
reliably reproducable and was dropped in favour of a membrane bound 
receptor preparation (Briley et al.t1979)« This system initially 
gave a of 30 |iM for L-glu, but further refinement finally showed 
two populations of L-glu binding sites, having values of 12.5nM 
and 1.3mM (Briley et al.t1982). A putative L-glu receptor has also 
been shown on thoracic muscle membranes of the housefly Musca 
domestica (Filbin et al. t1985). This receptor shows a of 0.5|iM, 
and a displacement profile similar - but by no means identical - to 
that found early on in the work on the mammalian CNS receptor for 
L-glu. It would thus appear that the Insect work is at a stage 
similar to that attained in the mammalian work in the early 1980's.
There would appear to be no reports of L-glu radioligand binding in 
the CNS of insects.
1.5 The role of GABA as a neurotransmitter in the insect
A neurotransmitter role for GABA (XVII) was accepted much more 
readily than for L-glu (I) because of the much less important role 
this amino acid plays in intermediary metabolism. Most of Herman's 
criteria for the indentification of a compound as a neurotransmitter 
(Herman:1966; see above) have been fulfilled by GABA in mammalian 
systems.
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a) Presence in the neurotransmitter pool: GABA was shown to be one
of the amino acids present in the extracts made from mouse 
brains by Roberts and Frankel (1950)
b) Release: With the small quanities released on nerve stimulation,
this can be difficult to show in vivo. However, Obata and 
Takeda (1969) have shown that calcium ions induce the release 
of endogenous GABA into the fourth ventricle of the cat and 
the release of preloaded radiolabelled GABA by the use of 
depolarising agents on cortical slices (Srinivasen et_al.: 
1969) and synaptosomes (De Belleroche and Bradford:1972) is 
also calcium dependent,
c) Identity of action: GABA has been shown to have an inhibitory
action similar to the natural transmitter in central neurons 
(Curtis and Watkins:1960b)
d) Synthesis and degradation: GABA is synthesised by glutamate
decarboxylase (GAD). Levels of this enzyme in various areas 
of the brain correlate well with the GABA content of that 
area (Fonnum et al.:1970)« In fact GAD is now used as a 
major cytochemical marker for the identification of 
GABA-ergic neurons (Wood et al.:1976). GABA is degraded via 
the enzymes ¿T-amino-butyric acid transaminase (GABA-T) and 
succinic semialdehyde dehydrogenase (SSA-D). Both these 
enzymes are found in regions similar to those containing GAD 
(Salvador and Alberts:1959)
e) Removal: Removal of GABA from the synaptic cleft is believed to
be by uptake into the glial cells. High etffinity, 
sodium-dependent uptake into these cells has been shown (Henn 
and Hamberger:1971).
GABA is now also accepted as the major inhibitory transmitter in 
insects.
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1.5.1 The electrophysiological evidence for GABA as a 
neurotransinitter at the insect nmj and the insect CNS.
GABA is accepted as the major inhibitory transmitter at the insect 
nmj. Experiments carried out in vertebrate models such as the cat 
cortical neurones (Krnjevic and Schwartz:1967) and cat spinal 
raotorneurones (Curtis et al.:1968) paved the way for this acceptance, 
as did similar work on the crustacean nmj (Takeuchi and 
Takeuchi: 1965). Using the extensor tibia muscle of the metathoracic 
leg of the locust S.gregaria Usherwood and Grundfest showed in 196A 
that GABA could mimic inhibitory post synaptic potentials and in 1965 
that these could be blocked by PTX (XLII). In his 1980 review, 
Usherwood could say that the role of GABA as the inhibitory 
transmitter at the insect nmj was readily accepted.
In 1980, Brookes and Werman studied the effect of ion concentrations 
upon the reponsiveness of the flexor tibialis muscle of the locust 
Locusta migratoria. From the Hill plots obtained in their 
experiments they were able to show that the number of GABA molecules 
needed to activate the receptor/ionophore complex varied between 2 
and A, depending upon the ionic conditions used in the test bath. 
Using a saline that mimics physiological conditions they found that 
the number of GABA molecules needed for activation was 3. This 
suggests that the receptor can adopt at least three states dependent 
upon the ionic environment.
As with the nmj, so with the CNS of the insect; GABA is readily 
accepted as a neurotransmitter. As long ago as 1969 Kerkut et al. 
showed that the abdominal ganglion of the cockroach P.amerlcana was 
inhibited by very small amounts of GABA (10 moles), Roberts et al. 
(1981) have since shown that this inhibitory effect is mediated by a 
receptor which accepts GABA in the partially extended form. They 
showed that the GABA agonist dihydromuscimol (XXII) was the most 
potent of those compounds which they tested on both P.amerlcana and 
L.polyphemus central neurones.
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1.5.2 The evidence of receptor binding studies for GABA as a 
neurotransmi tter.
As with L-glu, most of the work into the radioligand binding 
properties of the GABA receptors have been carried out on membrane 
fractions derived from the rat brain. Such studies show some of the 
dangers in the interpretation of receptor binding assays, for it is 
possible to define up to 36 different sub-types of the GABA receptor 
(Beart;1982). These have been resolved into two major groups - the 
GABA^ and the GABAg receptors. The GABA^ site is postulated as the 
classical receptor site for the action of GABA as an inhibitory 
neurotransmitter, the action of GABA at this site being classically 
antagonised by bicuculline (XLI). This site will be dealt with in 
more detail below.
The uncovering of the GABAg site arose from the work of Bein (1972) 
and Kerberle and Faigle (1972), which led to the production of 
Baclofen (XXXVI). This compound caused the inhibition of cat spinal 
reflexes in a bicuculline-insensitive manner. Radioligand binding 
studies at first showed that this compound did not displace 
specifically bound GABA from the normal membrane preparations. 
However, when CaCl2 was added to slightly modified buffers 
(containing Tris-HCl as opposed to Tris-citrate to avoid the 
chelation of the Ca^ '*'), the amount of GABA bound was found to 
increase in a manner that was sensitive to the addition of Baclofen. 
These conditions also reveal specific binding of radiolabelled 
Baclofen (Hill and Bowery: 1981). The exact role of the GABAg sites 
is uncertain, but they may be involved in the presynaptic modulation 
of release of neurotransmitters. The area is reviewed by Bowery 
(1982).
The GABA^ receptor in the mammal is part of a supramolecular complex 
which includes the Cl” ionophore and binding sites for 
benzodiazepines and barbiturates. The three major binding sites on 
this complex will be considered below. Useful reviews of this area 
are provided by Enna (1981) and Olsen (1981).
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1.5.2.1 The GABA^ recognition site.
Studies on the GABA^ recognition site are usually carried out using 
freeze-thawed and Triton X-100 treated membranes in sodium free 
Tris-citrate buffer (Enna and Snyder: 1977). For a long time the 
major displacer used at this site was the GABA-mimetic, muscimol 
(XXI). However, this compound is known to have other actions besides 
those mediated through the GABA^^ receptor, being also a GABA uptake 
blocker and a substrate for GABA-T. In order to better study the role 
of the GABA^ receptor, more specific GABA agonists were developed.
The three main ones were
A ,5,6,7-tetrahydroisoxzolo[5,A-c]pyridin-3-ol (THIP:XXIII), 
isoguvacine (XXIV) and piperidine-A-sulphonic acid (XXV). Although 
all of these compounds are less potent than muscimol at displacing 
GABA from its recognition site (isoguvacine and
piperidine-A-sulphonic acid are about as potent as GABA, whilst THIP 
has only one fifth the activity), they all show greater specificity 
for the receptor site. All of these were reported by 
Krogsgaard-Larsen and Falch (1981).
1.5.2.2 The benzodiazepine recognition site.
Benzodiazepines are a group of compounds possessing relaxant, 
hypnotic, anti-convulsant and anxiolytic properties. Many of these 
actions seem to be mediated through receptors allosterically linked 
to the GABA^ receptor site, binding to this site causing a 
facilitation of GABA function. This site binds the benzodiazepine 
representative [^H]-flunitrazepam (LI) with high affinity (a value 
of 1.5AnM). In the presence of GABA or agonists such as muscimol the 
amount of the radioligand bound is increased due to an increase in 
the binding affinity (the is reduced to 0.90nM). The GABA 
antagonist bicuculline was found to reduce the amount of 
flunitrazepam bound (Wong et al.t1980).
Rigid GABA agonists such as THIP and piperidine-A-sulphonic acid are 
unable to produce this increase in the binding of benzodiazepines at 
0®C (Krogsgaard-Larsen and Falch:1981). However, the addition of Cl 
ions or the elevation of the incubation temperature to 30®C enabled 
these agonists to mimic GABA in the increase of the binding affinity
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of the flunitrazepam (Supavilai and Karobath: 1980)
Various endogenous ligands have been proposed for these receptor 
sites, but none have gained general acceptance. Thus in a paper in 
1981, Mohler suggested the following possibilities; inosine, 
hypoxanthine, nicotinamide, ethyl-^- carboline-3-carboxylate, 
thromboxane and GABA-modulin. The search for an endogenous ligand 
still continues.
1.5.2.3 The chloride ion ionophore.
The chloride ion ionophore is believed to be the site of action of 
compounds such as PTX and the other cage convulsants. Much work has 
been carried out using PTX reduced with tritium as a ligand for this 
site (eg. Leeb-Lundburg et al.: 1981). However, dihydropicrotoxinin 
(DPTXtXLIII) has proved to be a poor ligand because of the high level 
of non-specific binding associated with its use. Since then, two 
cage convulsants have provided more suitable ligands for this site. 
They are t-butyl-bicyclophosphorothionate (TBPStXLVI), labelled with 
and t-butyl-bicylcoorthobenzoate (TBOBrXLVII), labelled with ^H. 
Both these ccxnpounds act on the same receptors as PTX (Casida et al.; 
1985; Lawrence et al.;1985). All of these compounds act by blocking 
the ionophore and as such act as non-competitive GABA antagonists in 
electrophysiological studies, having no effect in radioreceptor 
studies on the binding of GABA.
Other compounds which displace these ligands from this site are the 
convulsant benzodiazepine R05-3663 (LID and the barbiturates (Olsen 
and Leeb-Lundberg: 1981). Thus this unusual benzodiazepine would 
seem to work by blockage of the Cl” channel, whilst the barbiturates 
work by prolonging the opening of it. There is also an allosteric 
interaction between the barbiturates and the other two sites as they 
can enhance the binding of both the high affinity GABA sites in 
certain circumstances (using fresh membranes as opposed to the 
normally employed freeze-thawed and detergent washed membranes; 
Johnson and Willow: 1981) and can also enhance the binding of the 
benzodiazepines (Stephenson and Olsen: 1982).
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A schematic diagram of the GABA^/Cl” channel complex is given in 
Figure 1.5.
1.5.3 The binding of the various classes of GABA/Cl” channel 
complex ligands to membranes derived from insect tissue.
Radioligand binding studies with GABA have proved harder to perform 
in the insect than those using L-glu. This is presumably due to a 
higher level of non-specific binding to be expected using a ligand 
with a lower charge and thus more lipophilic. Despite this, more 
groups have investigated the insect GABA receptor than is the case 
for the L-glu receptor and investigations have been carried out on 
all of the three sites involved in the complex.
The initial work on the binding of compounds to the GABA receptor 
site in arthropods was carried out by Olsen's team (Olsen et al.t 
1975; Meiners et al.; 1979). In 1982, Briley et al. made a 
preliminary report on the discovery of muscimol binding to a membrane 
fraction from the muscle of S.gregaria. This was to the same 
fraction as that used to show L-glu binding in the locust muscle. 
However, it was only recently that the presence of a specific GABA 
receptor in insect CNS was reported. In 1985 a number of groups 
showed such activity in a number of insect species:
i) Breer and Heilgenberg reported the presence of one class of 
Na'*’- independent sites for muscimol with a of 0.1 mM
in the CNS of L.migratoria.
ii) Lummis and Sattelle, working on the cockroach P.americana, 
found a receptor site which bound GABA with a of
0.38pM. This site showed properties that were characteristic
of neither the GABA, nor the GABA„ sites in mammals.A B
iii) Lunt et al. studied both S.gregaria and M.domestica and found 
specific sites in the CNS of each of these species, the
were 10 and AOnM respectively.
All these investigators found the Hill coefficient to be close to 
unity, indicating that there was no cooperativity between the 
receptors.
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Figure 1.5
A schematic representation of the GABA/Cl” cheuinel complex.
This diagram is taken from Krogsgaard-Larsen and Falch (1981). It 
shows the typical GABA-ergic terminal with the various receptor sites 
to be found on the post-synaptic GABA/Cl" channel complex receptor.
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The Cl” channel in arthropods was also first investigated using 
ligand binding techniques by Olsen and his team on crayfish muscle, 
where they claimed to have found a site that specifically bound DPTX 
(Olsen et al.t 1978). The presence of a similar site in P.americana 
CNS was reported by Tanaka et al. in 198A. This had a value of 
0.8 i^M. More recently, work on the ionophore site has been undertaken 
using the bicyclophosphate ligand [^^S]-TBPS. Cohen and Casida 
(1985;1986) have shown the presence of specific TBPS binding in 
housefly muscle preparations, whilst Lunt et al. (1985) give 
preliminary reports of such binding in a preparation from the head of 
the same species. The values recorded varied between 10 and 
210nM, but in each case the reported Hill coefficient was close to 
unity.
Finally benzodiazepine receptors have also been sought in insect 
tissue. Preliminary results suggested that these receptors did not 
exist in insects. Thus both Nielsen et al. (1978) and Maggi et al. 
(1980) undertook work which indicated that benzodiazepines receptors 
were of a late evolutionary appearance. However, in 1983 Abalis £t 
al. discovered two sites that specifically bound flunitrazepam in the 
thorax muscle of the housefly (K^ values of 2k and 99A nM), whilst 
Robinson et al. (1985) found a single site in the CNS of both locust 
and housefly (K^ values around 50nM). The work of the latter group 
suggested that the reason for the failure of earlier groups to find 
these sites was the lack of Ca^ "*" in the medium, as this ion was found 
to be essential to reveal the binding sites with which they were 
dealing.
The nature of the interactions between these three sites have not 
been fully investigated as yet, but it would appear that the insect 
CNS does contain a GABA/Cl” channel complex that bears many 
similarities to the one found in mammalian systems.
1.6 The scope of the present study
In the search for new insecticides there is a need to evaluate the 
intrinsic activity of candidate compounds on their putative target 
site as well as to determine the overall toxicity of these entities 
to the target species. This need arises because many compounds do
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not reach the target site, being prevented from doing so by such 
factors as metabolism and difficulties in penetration. To reject 
such compounds on the basis of toxicity data alone is to run a grave 
risk of ignoring potentially fruitful chemical leads. And once a 
lead has been established, radioligand binding studies can be used to 
establish quantitative stucture activity relationships and so aid the 
chemists in the production of the most potent compound in the 
shortest time. Receptor binding studies offer the scope for a high 
throughput, low cost screening system for such compounds. These 
systems have been used in screening new psychoactive drugs (Creese: 
1985), why should they not be used in the development of pesticides? 
One major aim of this study was to provide such a system to aid in 
the development of novel series of insecticides acting through the 
neuroreceptors for the amino acids L-glu (I) or GABA (XVII).
A secondary aim was to fill some of the gaps in the knowledge of the 
biochemistry of the insect receptors for the amino acids L-glu and 
GABA. For although there has now been some considerable work 
undertaken to extend the biochemical investigation of the amino-acid 
transmitter receptors into the insect field, this area of study is 
still far behind the biochemical studies in mammals and the field of 
biochemistry is far behind that of electrophysiology in this whole 
area.
The CNS of the American cockroach was chosen as the major target 
tissue for the following reasons:
a) The American cockroach is a major pest. It is frequently found
in hospitals and eating areas, as well as in many homes. It 
may be a carrier of human pathogens and is the cause of much 
food spoilage (Roth: 1981). In the U.S.A. alone, the market 
for entities which control the roach pest is £A00M; clearly a 
method of control of this pest would be of economic interest.
b) The species breeds rapidly and has a comparatively large CNS
(60mg wet weight), thus plenty of material is readily 
available for study.
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2.1
2 . 1.1
Sources of Materials
Chemicals and Solvents
Unless stated to the contrary, the chemicals used were from the 
following sources
General chemicals and solvents - British Drug Houses, Broom Road,
Poole. BH12 ANN
(Analar Grade where available).
Biochemicals - Sigma, Fancy Road, Poole. BH17 7NH
Radiochemicals - Amersham International, P.O. Box 16, Amersham.
HP7 9LL (AI)
or - New England Nuclear/Du Pont, Wedgewood Way, 
Stevenage. SGI AON (NEN).
2 . 1.2
Cockroaches
Insects
I ■<
Adult male Periplaneta americana were reared in 
the Applied Biology Section at Wellcome 
Research Laboratories, Berkhamsted Hill. Their 
diet consisted of calf-nuts and water ad lib, 
and they were maintained at 26®C.
Green Bottle Flies : Adult Lucilla sericata were supplied by the
Veterinary Entomology Section, Coopers Animal 
Health, Berkhamsted Hill. They were maintained 
on a diet of sugar and water ad lib until 
required. The temperature of the holding room 
was maintained at 26®C and a 12 hour light/dark 
cycle was used.
Locusta migratoria were reared in house in 
Griffin and George locust cages. The cages 
were kept in a holding room maintained at 28® 
and 20% relative humidity, with a 12 hour 
light/dark cycle. The locusts were fed fresh 
cut grass and water. Fully developed adults 
were used for the experiments.
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Schistocerca gregarla were purchased from 
Bioserv Ltd.
Unless otherwise stated, all procedures described were carried out at 
A°C.
2 .2 Measurement of radioactivity.
Radioactivity was measured by liquid scintillation counting using an 
Intertechnique SLAOOO scintillation counter.
For ^ -particle emitters ( H, C, S), samples were added to the 
Triton/xylene based scintillation medium Instagel (Packard 
Instruments Ltd) and counted using the appropriate factory set gates. 
The counting efficiency for each series of experiments was 
determined by replicate determinations of the cpm from a known amount
3
of the appropriate radioactive standard (usually [ H] - or 
1A[ C]-n-hexadecane, ex AI).
For the /-emitter ^^^I, samples were placed in polythene inserts and 
counted on the SLAOOO in /-vials (Koch-Light Ltd) using the factory 
settings for The counting efficiency was determined by counting
replicate samples containing a known amount of /-emitting substance.
2.3 The binding of ligands to a potential glutamic acid
receptor In membranes derived from P. americana central nervous 
tissue.
2.3.1. 3The binding of [ H]-L-glutamic acid.
The procedures used to prepare membranes to study the binding of
3
L-[ H]-glu (I) are schematically laid out in Figure 2.1.
2.3.1.1 Gray and Whittaker (1962) published a method for the
preparation of synaptosomes from whole rat brains. This method was 
followed to produce synaptosome-like material from P. americana 
central nervous tissue. This material was then osmotically and 
sonically shocked to give membranes suitable for binding assays.
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The method used was as follows:
Total central nervous tissue (cerebral, thoracic and abdominal 
ganglia) were dissected and homogenised in 0.32M sucrose (pH 7.2 with 
Tris base) using 12 strokes of a Jencons 'Uniform' 15ml glass in 
glass homogeniser. The homogenate was centrifuged at 1000 x g(max) 
for 10 minutes, and the supernatant re-centrifuged at-<i000 x g(max) 
for A5 minutes. The resulting pellet (P^) was resuspended in 3mls 
0.32M sucrose, and carefully layered on top of a sucrose 
step-gradient consisting of 6mls of each of 1.2M and 0.8M sucrose (pH 
7.2 with Tris base). The step gradient was centrifuged at 150000 x 
g(max) for 60 minutes. The synaptosomal material was removed from 
the boundary between the 0.8M and 1.2M sucrose using a 10ml syringe 
with a wide-bore (19 gauge) 90® needle. This was added to a 100ml 
measuring cylinder and slowly diluted with an equal amount of 
distilled water. This solution was centrifuged at 38000 x g(max) for 
A5 minutes. The resulting pellet was osmotically shocked by 
resuspension in 2mls distilled water, and then sonicated in a Kerry 
'Sonibath' for a total of 3 minutes. This was finally centrifuged 
38000 X g (max) for A5 minutes, and the pellet used for the binding 
experiments as described below (2.3.1.3.).
2.3.1.2. A method closely following that used by Sharif and
Roberts (1980) to produce synaptic membranes from rat brains was 
used. The method used differed slightly in the production of the 
final pellet following the sonication and washing phase.
Total central nervous tissue was dissected and homogenised in 0.32M 
sucrose (pH 7.2 with Tris base) using 10 strokes of a 15ml Jencons 
'Uniform' glass in glass homogeniser. The homogenate was centrifuged 
at 1000 X g(max) for 20 minutes and the supernatant carefully 
removed. This was re-centrifuged at 17000 x g(max) for 20 minutes. 
The resulting pellet (Pg) was resuspended in distilled water, and 
sonicated for 3 minutes using a Kerry 'Sonibath'. The homogenate was 
pelleted and washed twice by resuspension in distilled water, and a 
final pellet produced by centrifuging at 38000 x g(max) for 15 
minutes. This washed ?2 was then used for binding experiments 
( 2 . 3 . 1.3 ) .
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Total central nervous tissue (cerebral, thoracic and abdominal 
ganglia) were dissected and homogenised in 0.32M sucrose (pH 7.2 with 
Tris base) using 12 strokes of a Jencons ’Uniform’ 15ml glass in 
glass homogeniser. The homogenate was centrifuged at 1000 x g(max) 
for 10 minutes, and the supernatant re-centrifuged ati^OO x g(max) 
for A5 minutes. The resulting pellet (P^) was resuspended in 3mls 
0.32M sucrose, and carefully layered on top of a sucrose 
step-gradient consisting of 6mls of each of 1.2M and 0.8M sucrose (pH 
7.2 with Tris base). The step gradient was centrifuged at 150000 x 
g(max) for 60 minutes. The synaptosomal material was removed from 
the boundary between the 0.8M and 1.2M sucrose using a 10ml syringe 
with a wide-bore (19 gauge) 90® needle. This was added to a 100ml 
measuring cylinder and slowly diluted with an equal amount of 
distilled water. This solution was centrifuged at 38000 x g(max) for 
A5 minutes. The resulting pellet was osmotically shocked by 
resuspension in 2mls distilled water, and then sonicated in a Kerry 
’Sonibath’ for a total of 3 minutes. This was finally centrifuged 
38000 X g (max) for A5 minutes, and the pellet used for the binding 
experiments as described below (2.3.1.3.).
2.3.1.2. A method closely following that used by Sharif and
Roberts (1980) to produce synaptic membranes from rat brains was 
used. The method used differed slightly in the production of the 
final pellet following the sonication and washing phase.
Total central nervous tissue was dissected and homogenised in 0.32M 
sucrose (pH 7.2 with Tris base) using 10 strokes of a 15ml Jencons 
Uniform’ glass in glass homogeniser. The homogenate was centrifuged 
at 1000 X g(max) for 20 minutes and the supernatant carefully 
removed. This was re-centrifuged at 17000 x g(max) for 20 minutes. 
The resulting pellet (P2 ) was resuspended in distilled water, and 
sonicated for 3 minutes using a Kerry ’Sonibath’. The homogenate was 
pelleted and washed twice by resuspension in distilled water, and a 
final pellet produced by centrifuging at 38000 x g(max) for 15 
minutes. This washed P^ was then used for binding experiments 
( 2 . 3 . 1.3 ) .
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Figure 2.1.
Methods of membrane preparation to study glutamate binding.
Schematic outline for the preparation of membranes from P. americana
3
central nervous tissue to study the binding of L-[ H]-glu (I). The 
methods are based upon those of Gray and Whittaker (1962) and Sharif 
and Roberts (1980).
NB : Unless otherwise stated, all experiments used an
homogenisation rate of ICNS per 40pl of homogenisation 
buffer. Where washes were performed, these were all 
carried out in 5ml distilled water.
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2 .3.1.3 The final pellet was resuspended in 0.05M Tris/citrate
buffer (pH 7.1) to give a final protein content of between 0.01 mg/ml 
and O.lmg/ml. The binding assay was initiated by adding 360pl of the 
resuspended membrane preparation to 1.5ml conical test tubes (Vim, 
Sarstedt type 72,690) containing 20pl displacer and 20pl 
L-[G-^H]-glutamic acid. The [^H]-glu was diluted 1:35 from the stock 
solution (IpCi/pl; 30Ci/m mole; ex AI) to give a final ligand 
concentration of 50nM. Experiments were also carried out in which 
the binding saline was modified by the addition of various cations.
r I
The membranes were incubated at A®C for 20 minutes, and the assay was 
terminated by centrifugation. This involved transferring the assay 
solution to AOOpl fine pointed tubes (Wm. Sarstedt type 72,702) which 
were placed in pre-formed holders made from Rapid Araldite (R.S. 
Components Ltd). These were centrifuged at 100000 g(max) for 5 
minutes in a 'swing-out' rotor. The tubes were removed from their 
holders and the bulk of the supernatant aspirated and discarded. The 
tip of the tube containing the membrane pellet was removed and placed 
in a glass scintillation vial (F.G.B. Trident Ltd) containing 500pl 
Soluene (Packard Instruments Ltd). This was left over night before 
liquid scintillation counting.
2.3.2.
acid (APB).
The binding of D,L-[^H]-2-amino-A-phosphonobutyric
Membranes were prepared as described in Section 2.3.1.2. The pellet 
was resuspended in 0.05M Tris/citrate buffer (pH 7.1) for use in 
binding assays. The assay was carried out as described in Section
2.3.1.3 with the following modifications. The ligand used was 
D,L-[3,A-^H]-2-amino-A-phosphonobutyric acid diluted 1:30 from stock 
(i^ lCi/^ ll; 26.1Ci/m mole;ex NEN) giving a final ligand concentration 
of 30nM. The binding saline was also modified by the additon of 
CaCl2 , as suggested by Butcher et al (1983) after their studies of 
the binding of D,L-[^H]-APB (VI) to rat brain synaptic membranes.
2.3.3. The binding of [^H]-kainic acid
Three methods of membrane preparation were used to try to show the 
binding of [^H]-kainic acid (XIV). These are described below.
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2 3.3.1. Because it has been shown to produce membranes
containing glutamic acid receptors which show displaceable binding of 
L-[^H]-glu, the method of Sharif and Roberts (1980) was used (Section
2.3.1.2).
2.3.3.2. Membranes were also prepared using the method of
Staatz et al. (1983). This method was used to study the effects of 
pyrethrolds on the binding of [^Hl-kalnlc acid to membranes from the
mouse brain.
Total central nervous tissue was dissected and homogenised in glass 
distilled water using 20 strokes of a 15ml Jencons ’Uniform’ glass in 
glass homogeniser. The homogenate was centrifuged at 100000 x g(max) 
for 15 minutes. The supernatant was discarded and the pellet 
resuspended in glass distilled water and left to stand for 30 minutes 
at 37®C. The suspension was re-centrifuged and the pellet 
resuspended in 0.05M Tris/citrate buffer (pH 7.1) the solution was 
finally centrifuged at 100000 x g(max) for 15 minutes, and the pellet 
used for binding assays as described below (2.3.3.A)
2.3.3.3. Finally, membranes were prepared using the method of
Ruck et al. (1980) This method was used to study the binding of 
[^H]-kainic acid to rat cerebellum membranes.
Total central nervous tissue was dissected and homogenised in 0.32M 
sucrose (pH 7.1 with Tris base). The homogenate was centrifuged at 
1000 X g(max) for 10 minutes. The supernatant was re-centrifuged at 
20000 X g(max) for 20 minutes. The resulting pellet was resuspended 
in distilled water and sonicated intermittently for 20 seconds using 
a Dawe Soniprobe on maximum setting. The shocked membranes were 
centrifuged at 8000 x g(max) for 20 minutes. The supernatant was 
removed, and used to carefully rinse the pellet to remove its top 
(lighter) layer to produce an augmented supernatant (S^ )• This 
supernatant was centrifuged at A8000 x g(max) for 20 minutes. The 
pellet was washed by resuspension, and the final pellet stored at 
-25®C for 2A-72 hours.
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On the day of use, the pellet was thawed and resuspended in 0.05M 
Tris/citrate buffer (pH 7.1) using the Dawe Soniprobe. This was 
centrifuged at A8000 x g(max) for 10 minutes and this final pellet 
used in the binding assay.
2.3.3.A. For the methods described in Sections 2.3.3.1. and
2.3.3.2. the membranes were resuspended in 0.05M Tris/citrate buffer 
(pH 7.1) at a concentration of 1 CNS equivalent per AOOpl. 380pl of 
this homogenate were added to 20pl of displacer and 2pl of 
[^H]-kainic acid (IpCi/pl; 60Ci/m mole; ex NEN) giving a final ligand 
concentration of 80nM. This was incubated at A°C for 20 minutes, 
and the incubation stopped and counted as described in Section
2.3.1.3.
For the experiment described in Section 2.3.3.3. the procedure was 
similar, the only modification being that the membranes were 
resuspended at the equivalent of 1 CNS per 500pl, and A80pl of this 
homogenate were used per assay. This gave a final ligand 
concentration of 65nM.
2 .A . The binding of ligands to a potential GABA receptor
and related sites on the GABA/Cl' channel complex in membranes 
derived from P. americana central nervous tissue.
2.A.1
[ H]-muscimol.
The binding of ^-[^H]-amino butyric acid and
The experimental procedure follows that used by Enna and Synder 
(1977) to study the binding of [^H]-GABA (XVII) to rat brain synaptic 
membranes. The procedure followed is schematically described in 
Figure 2.2.
Total central nervous tissue was dissected and homogenised in 0.32M 
sucrose (pH 7.1 with Tris base) using 10 strokes of a Jencons 
•Uniform’ 15 ml glass in glass homogeniser. The homgenate was 
centrifuged at 1000 x g(max) for 10 minutes. The pellet (P-|) was 
discarded and the supernatant re-centrifuged at 20000 x g(max) for 10 
minutes. The resulting pellet (P2 ) was resuspended in distilled 
water and disrupted further by using a 2.51 Kerry ’Sonibath' for 10
- AO -
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minutes. The shocked membranes were centrifuged at 38000 x g(max) 
for AO minutes. The pellet (P3 ) was retained and stored at -26®C for
at least 18 hours.
On the day of use, the pellet was thawed and resuspended in 0.05M 
Tris/citrate buffer (pH 7.1) containing 0.05%(w/v) Triton X-100 (Koch 
Light, Colnbrook). The homogenate was incubated at 37°C for 30 
minutes and the detergent washed membranes harvested by centrifuging 
at 38000 X g(max) for AO minutes. This pellet was finally 
resuspended in 0.05M Tris/citrate buffer (pH 7.1, no Triton X-100) at 
a protein concentration of 0 .1mg/ml to 0.5 mg/ml. 360pl of this 
suspension were added to 20pl displacer and 20pl ^H-ligand. The 
ligands used were y'-[2 ,3-^H]-amino butyric acid (IpCi/pl; 60Ci/m 
mole; AT) diluted to give a final ligand concentration of 25nM; and 
[methyl-^H]-muscimol (1^lCi/^l; 20Ci/ra mole; ex AI) diluted to give a 
final concentration of 75 nM. After incubation at A«>C for 30 
minutes the assay was stopped as described in Section 2.3.1.3.
2.A.2. The binding of ligands directed at the Cl channel.
‘ >
Various Cl“ channel ligands are available for use, and three of these 
were tried out under various conditions.
2.A.2.1. The binding of [^H]-dihydropicrotoxinin (DPTX).
The method used to study the binding of [^H]-DPTX (XLIII) was based 
upon the method used by Olsen et_al. (1978) to study the binding of 
this ligand to membranes derived from crayfish muscle. The procedure 
used here differed from the original in missing out an initial high 
speed centrifugation and in adding the multi-function oxidase 
inhibitor piperonyl-butoxide to the binding medium. These 
modifications were used by Kadous et al. (1983) in their study of the 
binding of [^H]-DPTX to membranes derived from the central nervous 
tissue of the German cockroach, Blattella germanica
Central nervous tissue from the cerebral and three thoracic ganglia 
was dissected and homogenised in van Harreveld*s saline (NaC1.205mM, 
KCl: 5.AmM; CaClgt 13.6mM; MgCl2 : 2 .6mM; Tris HCl: 5niM; pH 7.9 by the 
NaOH) using ten strokes of a Jencons 15 ml ’Uniform* glass in glass
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homogeniser. The homogenate was centrifuged at 1000 x g (max) for 10 
minutes, and the resulting supernatant re-centrifuged at UOOOO x g 
(max) for 35 minutes. The pellet (P^) was retained.
The was resuspended at a protein concentration of 1-3 mg/ml in a 
binding saline consisting of 200mM NaCl; 5mM Na^PO^ at pH 7.0 (by 
HCl). To 380pl of this were added 2pl piperonyl butoxlde solution 
(0.676mg/ml, giving a final concentration of 10 M). Five minutes
later, 2\il [^H]-DPTX (IpCi/pl; 30Ci/m mole; a final concentration of 
20nM - ex NEN) and 20pl displacer were added. The tubes were 
incubated at A°C for 15 minutes before the assay was terminated and 
the membrane bound radioactivity estimated in the normal way.
2.A.2.2. 35The binding of t-[ S]-butylbicyclophosphorothionate (TBPS)
2.A.2.2.1. One method used was based upon that published by 
Ramanjaneyulu and Ticku (198A) to reveal displaceable binding of 
[ S]-TBPS (XLVI) to membranes derived from rat brains. Cerebral and 
thoracic ganglia were dissected and homogenised in ImM EDTA, pH 7.0, 
using a Jencons 15ml 'Uniform' glass in glass homogeniser. The 
homogenate was centrifuged at 1000 x g (max) for 10 minutes, and the 
pellet discarded. The retained supernatant was re-centrifuged at 
1AOOOO X g (max) for 20 minutes. This time the supernatant was 
discarded and the pellet (P2 ) retained. The P2 was then resuspended 
in ImM EDTA. This was then either dialysed overnight against 21 
distilled water, or washed twice by centrifugation and resuspension. 
The membrane suspension was finally centrifuged at 1A0000 x g (max) 
for 20 minutes, and the washed membranes resuspended in a buffer 
containing 200 mM KBr; 5 mM Tris HCl; pH 7.5( by KOH) and finally 
pelleted for use in binding assays.
2 . A . 2 . 2 . 2 . The method of Nicholson et al (1986) was followed.
This method has been shown to give synaptosomes with functional Cl* 
channels when using central nervous tissue from a wide variety of 
insects (L. sericata, S. gregaria, P. americana) as the starting 
material (See Figure 2.A).
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Cerebral and thoracic ganglia were dissected and homogenised in 0.25M 
sucrose buffered with 0.1M Tris to pH 7.2 using 20 strokes of a 30mm 
bore Whittaker type homogeniser. The homogenate was centrifuged at 
1000 X g (max) for 10 minutes. The supernatant was removed and stored 
on ice, whilst the pellet was washed twice by rehomogenisation. The 
combined supernatants were then centrifuged at 25000 x g(max) for A5 
minutes to produce a crude synaptosomal pellet (P^). The was then 
either used for the binding assay (normal) or osmotically shocked and 
washed to remove any endogenous Cl“ channel ligand which may have 
been present.
To shock the P^ it was resuspended in ImM EDTA, centrifuged at 38000 
X g (max) for AO minutes and washed by a second resuspension 
centrifugation cycle. This gave the ’shocked’
2.A,2.2.3. The binding assay was similar in all the above cases.
The membranes from Section 2.A.2.2.1. were resuspended in saline 
containing 200mM KBr; 5mM Tris HCl; pH 7.5 to give a membrane 
concentration equivalent to 1 CNS per AOOpl. The membranes from 
Section 2.A,2.2.2. were initially carefully resuspended in AOOpl 
0.25M sucrose buffered with 0.1M Tris, using a Jencons 1ml ’Uniform’ 
glass in glass homogeniser. These membranes were then carefully 
introduced into various binding salines (200mM KCl/5mM Tris HCl;
200mM KBr/5mM Tris HCl; 200mM KI/5mM Tris HCl; Nicholson et al.
(1986) Synaptosome saline - NaCl : 203mM; KCl : 3.ImM; CaCl^ : 1.9mM; 
MgCl^: 6 .6mM. Na^HPO^ : 2.AmM; NaH2P0^ : 2mM; Glucose: 8 .8mM; pH 7.2) 
to give a final membrane concentration equivalent to 1 CNS per AOOpl.
AOOpl of these homogenates were then added to Apl displacer (either 
PTX or cold TBPS) and 2pl [^^S]-TBPS (diluted 1:10 from a stock 
containing IpCi/pl; 99Ci/m mole; a final concentration of 6nM; this 
ex NEN). The experiments were incubated for 30 minutes at 25®C, and 
the incubation terminated by filtration : 2.5cm Whatman GF/B glass 
fibre filters were used with a Millipore filtration unit and pump and 
the membranes were washed with 2.5ml ice-cold binding saline. The 
filters, with the attached membranes and associated radioactivity, 
were estimated in the normal way.
Incision
n
•• »
Figure 2.3
A schematic view of the denervation of P. amerlcana coxa.
a. A ventral view of P. americana showing the area of 
cuticle to be removed.
b. A close up of the area exposed once the cuticle has 
been cut. This shows the meta thoracic ganglion (g), 
with the nerve trunks (2-5) to be severed. It is 
important to ensure nerves 3 and 5 are completely 
severed.
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2 . A . 2 . 3 . The binding of
1 - [ ]-phenyl-A-t-butyl-2,6,7-trioxabicyclo-[2,2,2]-octane (TBOB).
[^H]-TBOB (XLVII) is available in a solution of IpCi/pl at a specific 
activity of 55Ci/m mole (NEN), It was used diluted 1:5 from stock 
for the following experiments.
2.A.2.3.1. Once more, the method Ramanjaneyulu and Ticku (198A) 
was closely adhered to (Section 2.A.2.2.1.). Briefly, total central 
nervous tissue was dissected and the obtained using extensive 
washing, as previously described. The was then resuspended in 
0.2M KBr; 5mM Tris HCl; pH 7.5 so as to yield a membrane 
concentration equivalent to 3 CNS per AOOpl.
AOOp.1 of this homogenate was incubated with Apl displacer and Ipl
•j
[ H]-TBOB (giving a final TBOB concentration of InM) for AO minutes. 
The incubation was terminated by filtration; the filters being washed 
rapidly with 2 x 2ml ice-cold saline. The filters were then counted 
in the normal manner.
i
2.A.2.3.2. The method used by Lawrence et al. (1985) to study the 
binding of [ H]-TBOB to rat brain synaptic membranes was slightly 
modified. Total central nervous tissue was dissected and homogenised 
in ImM EDTA (pH 7.0) using 30 strokes of a 30mm bore Whittaker type 
homogeniser. The Pg was produced by centrifuging the homogenate at 
1000 X g (max) for 10 minutes, and re-centrifuging the resultant 
supernatant at 10000 x g (max) for 20 minutes. The pellet was washed 
by resuspension and centrifugation. This was done twice in ImM EDTA 
and once in 500mM NaCl; 50mM PO^^"; pH 7.5 (binding saline). The 
washed membranes were centrifuged at 25000 x g (max ) for 20 minutes.
The pellet was suspended in binding saline at a membrane equivalent 
of 12 CNS per ml. The incubation was initiated by adding 250pl of 
these resuspended membranes to 250pl binding saline containing Apl 
displacer and 1pl[^H]-TB0B - a final concentration of 0.8nM. The 
assay was incubated for 30 minutes at 30®C and the incubation stopped 
by adding 2ml ice-cold binding saline, followed by rapid filtration: 
for this assay, Whatman GF/C filters were used in place of the GF/B. 
The filters were washed with two lots of 2ml of ice-cold binding
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saline. The radioactivity associated with the membranes was 
estimated in the normal way.
2.5. The binding of ligands associated with amino-acid
coupled ion channels to membranes derived from other insect tissues.
2.5.1. The binding of ligands to membranes derived from P. 
americana coxal muscle.
2.5.1.1. Various electrophysiological results suggest that 
TBPS (XLVI) acts at peripheral rather than central sites in the 
insect (G. Lees and S. Irving, personal communications). To test the 
binding of [^^S]-TBPS to peripheral sites in the American cockroach, 
the coxal muscles of the metathoracic leg were carefully squeezed out 
using the flat of a scapel blade, and membranes prepared from these 
using the method based on that of Ramanjaneyulu and Ticku (198A) as 
described in Section 2.A.2.2.1. The binding assay was carried out as 
described in Section 2.A.2.2.3. with the membranes being resuspended 
in the KBr/Tris binding saline at the equivalent of four coxa per 
AOOpl.
2.5.1.2. Denervation of muscles has been shown to increase the 
neurotransmitter receptor density on the denervated muscles (e.g. 
Usherwood 1969). The left metathoracic leg was denervated by 
carefully removing a flap of cuticle near to the top of the leg and 
cutting nerve trunks 3 and 5 from the metathoracic ganglion using a 
Wick microsurgical scalpel (supplied by J. Weiss and Son Ltd).
(Figure 2.3.). The flap of cuticle was replaced and the P. americana 
maintained for 21 days before using the coxa for binding experiments.
2.5.1.2.1. Sarcoplasmic membranes were prepared from the coxal 
muscles of right (normal) and left (denervated) metathoracic legs of 
P. americana treated as described in Section 2.5.1*2. These were 
prepared as described by Olsen et al. (1978) and used to study the
*5
binding of [ H]-glu (I) to such membranes.
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The metathoracic legs were removed and the coxa carefully squeezed 
out. These were homogenised in van Harreveld's saline using a 
Jencons 50ml 'Uniform' glass in glass homogeniser. The homogenate was 
centrifuged at 1A0000 x g (max) for 30 minutes. The supernatant was 
discarded, and the pellet resuspended in the original volume of 
saline. This was centrifuged at 1000 x g (max) for 10 minutes. The 
supernatant was stored on ice whilst the pellet was washed once. The 
combined supernatant was centrifuged at 1A0000 x g (max) for 30 
minutes to produce the microsomal pellet (P2 )«
The was resuspended in 3ml van Harreveld's saline and carefully 
placed on the top of a sucrose step gradient consisting of 6ml of 
each of 1.OM, 0.75M and 0.32M sucrose in lOOmM NaCl; 5mH Tris, pH 
7.7. This step gradient was centrifuged at 50000 x g (max) for 120 
minutes and the sarcoplasmic membranes harvested by collecting the 
material at the 0.75M/1.0M sucrose boundary. The membranes were 
centrifuged to give a final pellet which was used in binding studies 
with [^H]-glu, as described in Section 2.3.1.3.
2.5.1.2.2. Membranes were also prepared from the normal and 
denervated coxa to study the binding of [ H]-muscimol (XXI). The 
coxa from the right (normal) and left (denervated) metathoracic legs 
were removed and membranes prepared and used in the binding assay as 
described in Section 2.A.I.
2.5.2. The binding of radio-ligands to amino-acid related 
receptors in membranes derived from insects other than P. amerlcana.
2.5.2.1. The binding of [^H]-GABA to membranes derived from the
heads of L. sericata
L. sericata were chilled and then sieved with solid CO2 using a 
coarse 'Endicott' sieve. With vigorous shaking, the heads and 
thoraces separated, and the heads then fell through the sieve, 
leaving the thoraces behind. Membranes were then prepared from the 
separated heads and used for a binding assay as described in Section 
2.A.1.
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2.5.2.2. The binding of ['^H]-amino acids to membranes derived
from the cerebral and thoracic ganglia of the locust L» migratorla.
The method used by Breer and Jeserisch (1980) to produce synaptosomes 
from locust central nervous tissue was used to prepare membranes to 
study the binding of [^H]-glu and [^H]-GABA (XVII). The cerebral and 
three thoracic ganglia were dissected and homogenised in 0.25M 
sucrose; 0.1M Tris; pH 7.3 using 20 strokes of a 30mm bore Whittaker 
type homogeniser. The homogenate was centrifuged at 1000 x g (max) 
for 10 minutes. The supernatant was kept on ice, whilst the pellet 
was washed twice in half the original volume of sucrose. The combined 
supernatants were centrifuged at 25000 x g (max) for 20 minutes. The 
resulting supernatant was discarded and the pellet (P2 ) retained.
The P2 was carefully resuspended in 150pl sucrose containing 12%(w/v) 
Ficoll AOO (Pharmacia) and added to 750pl of the same. This was 
thoroughly mixed and centrifuged in AOOpl tubes at 10000 x g(max) for 
75 minutes. This produced a supernatant with a small floating 
'pellicle'. The supernatant, with the 'pellicle' was mixed with 
3.6ml of sucrose and centrifuged at 25000 x g (max) for 20 minutes to 
produce the synaptosomal pellet (P^)»
2
The membranes so produced were used to study the binding of [ H] -
3
glutamic acid (as described in Section 2.3.1.3) and [ H]-GABA ( as 
described in Section 2.3.3.A.)
2.6. A study of the enzymes Involved in the Immediate
production and degradation of GABA in P. americana central nervous 
tissue.
2 . 6 . 1 . Glutamic acid decarboxylase (GAD)
This method of obtaining and estimating the activity of GAD is based 
upon methods used to obtain the bacterial enzyme, as modified for 
screening purposes by Helen White of the Burroughs Wellcome Co. in 
America (White: 1981). Whole central nervous tissue was dissected 
and homogenised in a buffer consisting of : 0.1M potassium phosphate; 
0.5% (w/v) Triton X-100; ImM pyridoxal phosphate, ImM dithiothreitol; 
pH 6 .9 . The homogenate was centrifuged at 16000 x g (max) for 30
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minutes and the pellet discarded. The supernatant was brought to 25% 
saturation with ammonium sulphate and stirred gently for 60 minutes. 
The solution was centrifuged at 16000 x g (max) for 30 minutes and 
the pellet discarded once more. The supernatant was brought to 45% 
saturation with ammonium sulphate and stirred gently for 60 minutes 
before once more centrifuging at 16000 x g(max) for 30 minutes. This 
time the pellet was retained, and resuspended in a buffer containing 
0.1M potassium phosphate; ImM pyridoxal phosphate; ImM 
dithiothreitol; pH 6.9. The resuspended membranes were dialysed 
against at least 1000 volumes of the resuspension buffer for 6 hours, 
and the resulting suspension stored at -20®C for up to three months, 
and slowly thawed before use.
A Pierce-Wariner 3.5ml 'Reactivial' was used as the reaction vessel. 
lOOpl of reaction buffer (0.1M potassium phosphate; ImM pyridoxal 
phosphate; O.ImM dithiothreitol; pH 6.9) and 25|il 0.03M glutamic acid 
containing 1.25pCi [U- C]-glutamic acid (ex AI) were carefully added 
to the bottom of this. The reaction was initiated by adding 25pl of 
the enzyme preparation. A wick (1cm x 1cm Whatman No.1 filter paper) 
soaked with 25pl of 10% hyamine 10-X hydroxide in methanol was 
carefully wrapped around the septum, inserted into the reaction 
vessel and the cap screwed on well. The vessel was then incubated 
for 30 minutes at 37®C.
The incubation was terminated by carefully introducing lOOpl of 10%
trichloracetic acid into the reaction vessel using a gas
chromatography syringe (S.G.E. Limited) introduced through the
septum. The vial was allowed to stand for 60 minutes to allow the
1 A 1 Aevolution of the CO^ to be completed. The CO2 was produced by 
the decarboxylation of the [^^C]-glu, and was trapped by the hyamine 
wick. This was counted in the normal way.
2 .6 .2 . ^-Aminobutyric acid transaminase (GABA-T)
This method is a shortened version of that used by Watts and Atkins 
(1983) to study GABA-T in the nematode Nippostrongylus braziliensis. 
Total central nervous tissue was dissected and rinsed in lOmM 
potassium phosphate buffer, pH 7.2 The tissue was then homogenised 
in a buffer consisting of 50mM potassium phosphate; O.ImM reduced
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glutathione; 0.03mM pyridoxal phosphate; 0.2% (v/v) Triton X-100; 
pH 8.0; using 10 strokes of a Jencons 5ml ’Uniform' glass in glass 
homogeniser. The homogenate was centrifuged at 20000 x g (max) for 
30 minutes and the supernatant retained. This was brought to A5% 
saturation with ammonium sulphate and stirred gently for 60 minutes. 
The solution was centrifuged at^AOOO x g (max) for 30 minutes, and » 
the supernatant ($2 ) retained.
For the standard assay, the S2 was dialysed overnight against a 
buffer containing : lOOmM potassium phosphate; 5mM dithiothreitol; 
0.1mM EDTA; O.OAmM pyridoxal phosphate; pH 8.0. After dialysis, the 
enzyme preparation was stored until required at -26®C.
For the preliminary investigations, the S2 was brought to 65% 
saturation with ammonium sulphate and stirred gently for 60 minutes. 
This was then centrifuged at AAOOO x g (max) for 30 minutes. The 
pellet (P^) was stored at -26®C until required, and the supernatant 
was dialysed as described above before storage.
To assay for GABA-T activity, 50pl of thawed enzyme preparation were 
placed in a 1.5ml conical test tube (Wm Sarstedt type 72,690) to 
which were added 25pl of assay mixture (dialysis buffer containing 
0.8mM 2-oxoglutarate and 0.8mM A-amino-n-[U-^^C]-butyric acid at a 
specific activity of 2.2Ci/mole-ex AI) and 25|il of buffer, with or 
without amino-oxyacetic acid. The reaction mixture was incubated at 
37®C for 30 minutes, and the reaction was stopped by adding lOpl 2M 
HCl.
The reaction products were separated from the unchanged GABA (XVII) 
by adding 1ml of a suspension of thoroughly washed Dowex 50W-X8 
(H'*’form) in distilled water (O.A g/ml). The tubes were briefly 
centrifuged in a Beckman TJ- 6  bench-top centrifuge to consolidate the 
ion-exchange resin. O.Aml of the supernatant was carefully removed 
and added to 0 . 8 ml distilled water so that the amount of [^^C] - 
radioactivity could be estimated in the normal manner.
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2.6.3 The effect of GAD and GABA-T inhibitors upon the
levels of GABA in the CNS of P.americana.
An experiment was carried out to study the effect of various 
compounds upon the levels of GABA found in the CNS of P. americana. 
120pg of each compound (Apl of aqueous solution containing 30mg/ml) 
were injected into the haemocoel using an SGE lOpl gas-tight syringe, 
introducing the needle through the intersegmental membrane between 
the 7th and 8th abdominal sternites. After 2k hrs in the normal 
culture conditions; the roaches were chilled and the total central 
nervous tissue dissected. Each CNS was individually homogenised in 
20pl absolute ethanol, using a Jencons 0.1 ml 'Uniform' glass in 
glass homogeniser. The homogenate was transferred to a Sarstedt 1.5 
ml concial test-tube and centrifuged briefly to precipitate the 
protein. 2pl aliquots were then removed for GABA estimation.
The GABA content was estimated by micro-dansylation. 1 pl[^^C]-GABA 
(22AmCi/mmole, ex AI) was added to the supernantant as an internal 
standard and the sample carefully freeze-dried in a Sarstedt 0.75ml 
concial test-tube (cat no. 72,680). To this were added: Ipl 0.2M 
NaHCO^; 3pl 2:1 acetone:water; Apl [^H]-dansyl chloride solution 
(containing 1.56mg/ml and JmCi/rnl, ex AI) This was incubated at 
37®C for 20 minutes, the reaction being stopped by freezing. Ipl of 
the reaction product was then spotted onto a 7 .5cm x 7 .5cm polyamide 
thin layer chromatography plate (Schleicher and Schull) and developed 
in two dimensions - once in 3% aqueous formic acid and subsequently 
in 3:3:1 heptane:butanol:acetic acid.
The developed plate was visualised by U.V irradiation (25A nm) and 
the spot corresponding to dansyl-GABA outlined. This spot was then 
carefully cut out and counted, using gates set up for dual label 
counting of and The recovery of GABA was estimated using the
[^^C]-GABA as an internal standard (the recoveries varied from A5% to 
75%) and the original concentration of GABA in the sample estimated 
from the amount of [^H]-dansyl-GABA present on the piece of excised 
polyamide plate.
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Figure 2.A
The method used to prepare Insect synaptosomes for superfusion.
a. Flow chart showing the preparation and loading of 
insect synaptosomes ready for use in the superfusion 
system.
b. A diagramatic representation of the superfusion system. 
This method is as described by Nicholson et al. (1986).
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2 ^ 'j The production of synaptosones from the central
nervous tissue of P. americana and their use in transmitter release 
studies.
This method, a modified version of the one developed by Breer and 
Jeserisch (1980), was described by Nicholson et al. (1986). Head and 
thoracic ganglia were dissected and homogenised in 0.25M sucrose 
buffered with 0.1M Tris at pH 7.2, using 20 stokes of a 30mm bore 
Whittaker type homogeniser. The homogenate was centrifuged at 1000 x 
g(max) for 10 minutes. The supernatant was removed and stored on 
ice, and the pellet was washed twice by resuspension and 
re-centrifugation, the supernatants from each wash being combined 
with the original supernatant. The combined supernatants were 
centrifuged at 25000 x g (max) for A5 minutes, giving a pellet (P2 ) 
which was retained. The P2 has been shown to contain considerable 
numbers of intact synaptosomal profiles when viewed under the 
electron microscope (Nicholson et al. 1985).
The ? 2 was carefully resuspended in O.Aml Tris buffered 0.25M sucrose 
using a Jencons 1ml 'Uniform* glass in glass homogeniser. The 
homogenate was then slowly introduced into 1 . 6  ml oxygenated saline 
consisting of: NaCl:203mM; KCl:3.1mM; CaCl2 s1 «9mM; MgCl2 s6.6mM; 
Na2HP0^: 2.AmM; NaH2P0^: 2mMj Glucose : 8 .8mM; pH 7.25. This was 
preincubated at 30®C for 5 minutes. The synaptosomal solution was 
then added to lOOpl saline containing 50pCi [methyl- H]-choline 
(IpCi/pl; 80Ci/m mole; ex Al) and incubated for 15 minutes at 30®C.
lOOpl of the [methyl-^H]-choline loaded synaptosomes were carefully 
placed onto Whatman GF/B filters held in Millipore Swinnex filter 
holders, and then washed onto the filters using 3 x 200pl saline.
The synaptosomes were then superfused with 30ml oxygenated saline 
followed by 20 ml saline containing the various compounds to be 
tested. The flow rate was roughly 0 .8ml/minute maintained by a 
Watson Marlow 502U peristaltic pump, and fractions were collected 
every 3 minutes using an LKB Ultrorac II fraction collection. The 
amount of "^ H present in each fraction was estimated in the normal 
way.
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Figure 2.A shows a flow chart of the preparation and a diagramatic 
representation of the superfusion system.
2.8 Miscellaneous experiments
2.8.1. The binding of D,L-[pyrrolidinyl- H(N)]-nicotine to
membranes derived from the central nervous tissue of P. americana.
In this experiement, the binding of ["^Hl-nicotine (LX) and [ H]-glu 
(I) to the same synaptosomal membrane fraction was compared. The 
method used was based upon Breer (1981) in which he did some of the 
initial work on characterising his locust central nervous tissue 
derived synaptosomes. The major modification involved replacing 
sucrose by mannitol. Total central nervous tissue was dissected and 
homogenised in 0.25M mannitol; 1M EDTA; pH 7.A using 10 stokes of a 
Schutt Teflon in glass homongeniser. The homogenate was centrifuged 
at 1250 X g (max) for 10 minutes and the supernatant re-centrifuged 
at A5000 X g(max) for 10 minutes. The pellet (P2 ) was retained.
4
The P2 was carefully resuspended and transfered to the Schutt 
homogeniser using 2 x 150pl mannitol buffer. The tube was then 
rinsed with 1ml mannitol buffer supplemented with 12%(w/v) Ficoll 
AOO. The rinsings were added to the homogeniser and the P2 evenly 
dispersed using three strokes of the plunger. The homogenate was 
transferred to a centrifuge tube, and the homogeniser rinsed well 
with a further 0.7ml of the mannitol/Ficoll AOO buffer. The rinsings 
were added to the centrifuge tube, and the contents thoroughly but 
gently mixed. The resuspended P2 was centrifuged at 20000 x g (max) 
for 75 minutes. The supernatant was diluted with 2-3 volumes of 
mannitol buffer and re-centrifuged at 75000 x g (max) for 20 minutes 
to produce the synaptosomal pellet (P^).
P^ was resuspended in 5ml of 50mM Tris/citrate buffer (pH 7.1) and 
360pl used for binding assays. For [^H]-glu the procedure described 
in Section 3.2.1.2. was followed. For [^H]-nicotine 20pl of a 
diluted radioligand solution (diluted 1:150 frcnn stock, which was 
5pCi/pl, 35Ci/mmole; ex NEN) was used in place of [^H]-glutamate 
(giving a [”^ H]-nicotine content of 50nM), otherwise the same
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2 0 2  The binding of [^^^I]-bungarotoxin to membranes
derived from the central nervous tissue of S. gregaria
A crude ?2 was produced and was then further fractionated.
125j j_gjjngarotoxin was used to identify those fractions containing 
acetyl choline receptors, which are in turn a marker for synaptosomal 
membranes.
The total central nervous tissue was dissected from S. gregaria and 
was homogenised in 0.25M sucrose containing 0.1M Tris and ImM EDTA at 
pH 7.A using 10 stokes of a small motor driven Whittaker type 
homogeniser. The homogenate was centrifuged at 1000 g (max) for 10 
minutes, and the supernatant re-centrifuged at 20000 x g (max) for 20 
minutes. The supernatant was discarded, but the pellet (P2 ) was 
retained.
The ? 2 fraction was carefully resuspended in 2ml of the 
homogenisation buffer and carefully placed upon a discontinuous 
Ficoll step gradient. This consisted of 1ml of each 11%, 9%, 7%, 5% 
(w/v) Ficoll AOO in homogenisation medium. The gradient was spun at 
70000 X g (max) for 90 minutes.
The binding assay followed that used by Fertuck and Salpeter (1976) 
in their studies on the localization of acetylcholine receptors on 
mouse motor end plates. Each fraction from the step gradient was 
diluted to a protein content of between 0.25 and 2mg/ml using 
o(-bungarotoxin binding medium (NaCl:50mM; sucrose: 250mM; Tris: lOmM; 
BSA: 5mg/ml; pH 7.3). 360pl of each membrane solution was added to 
20pl diluted [^^^I]-bungarotoxin (1 : 1 0 0  from stock which was 
0.5mCi/ml; 200Ci/mmole; (AI) - a final concentration of 0.6nM). This 
was incubated for 90 minutes at 20®C, before stopping the incubation 
by transferring the assay medium to the AOOpl fine pointed tubes and 
harvesting the membranes by centrifugation. The tips of the tubes 
containing the harvested pellets were removed and the associated 
radioactivity counted.
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2.8.3.
homogenates,
A check for metabolism of ['^H]-TBOB by P. amerlcana
Central nervous tissue membranes were produced as described in 
Section 2.A.2.3.2. The was resuspended in the binding saline at a 
membrane concentration equivalent to 6 CNS per ml. To this was added 
IpCi [^H]-TBOB (XLVII), and this was incubated for 30 minutes at A°C, 
21°C and 37®C. The membrane solutions were then filtered through 
Millipore Swinnex disposable filters, and 15pl of the filtrate 
assayed by HPLC under conditions which would separate TBOB from its 
major metabolites. This involved a 10cm C-18 reverse phase column 
(Chrompack) with an eluting solvent of 70% methanol/30% water at a 
flow rate of O.Aml/min and maintained at a temperature of 20®C. The 
eluate was monitored at 2 1 0nm, and fractions for liquid scintillation 
counting were collected at one minute intervals.
2.9 Protein estimations
The two methods of protein estimation described below were used 
unsystematically, the method chosen being largely dependent upon the 
amount and range of protein contents expected in the samples. For 
small amounts, the Coomassie Blue method tended to be used, for large 
amounts, or a large range, the modified Lowry was used.
2.9.1. The method using Coomassie Brillant Blue G250.
This method was described by Sedmark and Grossberg (1977) and was a 
modification of the assay by Bradford (1976). Coomassie Blue G250 
was prepared as a 0.06% solution in perchloric acid, and filtered 
through a Whatman No. 1 paper. Protein solutions were prepared in 
0.5ml unbuffered saline and added to 0.5ml of the Coomassie Blue 
solution. The two were mixed, and the absorbance at 620nm read. A 
standard curve was prepared for each batch of protein estimations and 
the protein content calculated accordingly.
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2.9.2 The modified Lowry method.
This method was described by Peterson (1977) and was a modification 
of the original method of Lowry et al. (1951). The following stock 
reagents were made up:
1. Copper-tartrate-carbonate: A solution of about 20% 
sodium carbonate was added slowly with stirring to a 
copper sulphate/sodium-potassium tartrate solution to 
give final concentrations of 0 .1 % copper-sulphate; 
0.2% potassium tartrate, 10% sodium carbonate. This 
solution was stable for at least 2 months.
2. 10% sodium dodecyl sulphate,
3 . 0 .8M sodium hydroxide.
2M Folins - Ciocaltau phenol reagent.
From these the following working solutions were made:
Mix equal parts of 1, 2 and 3 and distilled water.
This solution will keep at least two weeks.
B, Solution A was diluted 1:5 with distilled water, and
kept in an amber bottle.
The protein was brought to between 5pg/ml and lOOpg/ml with distilled 
water, and 1ml of this added to 1ml Reagent A. This was allowed to 
stand for 10 minutes. 0.5ml of Reagent B was then added and rapidly 
mixed. This was allowed to stand for at least 30 minutes, and the 
absorbance of 750nm read between then and 2 hours after Reagent B had 
been added. Once more a standard protein curve was run with each set 
of samples.
All the procedures for protein estimation were carried out at 20®C.
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3.1 Statistics
Throughout this chapter, the methods outlined below were used to 
obtain the various statistical parameters.
3.1.1 Means and standard errors.
The group means and the standard errors of those means, were 
calculated using a Hewlett-Packard HP25 programable calculator.
3.1.2 Statistically significant differences between groups,
Where two or more groups have been treated for statistically 
significant differences, a package written in APL for the mainframe 
IBM370/1A8 computer was used. The program used Bartlett's test for 
homogeneity of group variances, (Bartlett 1937), followed by Duncan's 
multiple range test (Duncan 1955), or Shuster and Boyett's 
non-parametric method (Shuster and Boyett 1979) in cases where the 
normal restrictions for parametric statistical tests were not met. 
(Burch and Macpherson 1980).
3.1.3 Straight lines,
Data were fitted to straight lines by calculating the least squares 
fit using a Texas Instruments TI- 6 6 programable calculator.
3.2 Radioligand binding assays.
The results have been calculated by dividing the total binding into 
its component parts of 'specific binding* and 'non-specific binding'. 
The 'total binding* was taken as the total amount of radioactivity 
associated with the membranes and counted in the scintillation 
counter. The 'non-specific* component was taken as that portion of 
the radioactivity that associates with the membranes due to 
non-specific interactions; eg. lipophilicity, ionic interactions, van 
der Waal's forces, solution entrapped in the pellet, radioacitivity 
associated with the filter. This component was not saturable within 
the limits of experimentation. As the amount of radioligand was 
constant for each series of experiments, the 'non-specific* binding
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was independent of the amount of displacing compound added. It was 
estimated by adding a large excess of displacing compound, so that 
the amount of radioligand associated with the membranes due to 
receptor-ligand interactions was less than 0.1 % of the total counts 
present. The 'specific binding' was obtained by subtracting the 
'non-specific binding' from the 'total binding' and represents the 
amount of radioactivity associated with the membrane due to 
receptor-ligand interactions. It is on the 'specific binding' 
component that all the various transformations were carried out.
3.2.1 The Scatchard plot.
The plot of [bound ligand (B)]/[free ligand (F)] vs [bound ligand] 
was first used for receptor-ligand interactions by Scatchard (19A9) 
and is analogous to the Eadie plot of the Michaelis-Menten equation 
for enzyme kinetics (Eadie: 19^2). It assumes one type of receptor 
with a 1 : 1  interaction between the ligand and the receptor and is 
derived from the equilibrium equation for the interaction as below:
R + L i RL
where R represents the receptor, L the ligand and RL the 
receptor-ligand complex. Thus:
K g  = [ R L ]
[R][L]
But:
[R^] = [RL] + [R]
where R_ represent the total number of receptors present.
and:
[RL] = [B] ; [L] = [F]
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Thence:
= ([Rt 3 - [B])[F] 
[B]
or:
([R^] - [B])
Thus a plot of [B]/[F] vs [B] gives a straight line with a slope of 
-1/Kj and an intercept on the abscissa of [R™]. Should the initial 
assumptions be incorrect and more than one type of receptor exist, or 
the interaction between the receptor and the ligand prove not to be 
1 :1 , then the plot gives a curve.
This analysis was used for both the glutamate and the GABA receptors 
in those cases where the tritiated ligand was being displaced by an 
excess amount of the same cold material.
3.2.2. The Hill plot.
The Hill or logit plot is explained by Enna (1985). This is derived 
from the law of mass action for the following reaction equation:
R + nL ^ RL,n
Thus:
= [R] [L] 
[RL„]
n
Replacing as before:
= ([R^l - [B])[L] 
[B]
n
or:
[B]
([R^]-[B])
1 [F]n
11
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Taking logarithms:
Ig [B] = -IgK^ + n lg[F]
([R^]-[B])
Thus a plot of lg([B]/[R^]-[B]) against lg[F] will give a straight 
line for which the slope will give the number of ligand molecules 
binding with each receptor molecule and the intercept on the ordinate 
will give -IgKj» When the slope of the line is unity, this will show 
that the ligand and receptor molecules bind 1 : 1  and that there is no 
cooperativity in binding.
The value for [R^] obtained from the Scatchard plots constructed as 
in Section 3.2.1. was used to construct Hill plots for these 
experiments.
3 3 The binding of ligands to the glutamate receptor in
membranes derived from the central nervous tissue of P. americana.
The results of the various experiments undertaken to investigate the 
glutamate receptor are given below.
3.3.1 The binding of L-[^H]-glutamic acid.
For these experiments 'non-specific binding* was taken as that level 
of radioactivity remaining associated with the membranes in the 
presence of lO’^M cold L-glu (I). In the experiments using the 
method of Sharif and Roberts (Section 2.3.1.2) the non-specific 
binding varied between 20% and 50% of the total radioactivity bound 
at 5x10"®M glu. The standard error about the mean for groups of 
replicate samples was normally about 6% of the mean, but it was 
occasionally as high as 20% of the mean. The amount of membrane 
protein used for each assay was about 30pg.
Figure 3.1 gives graphical representations of results obtained from 
an experiment to show the displacement of the [^H]-glu from the 
membrane preparation by the addition of unlabelled glu. The 
Scatchard plot gave a value for the of glu and its membrane 
receptor of KSAxIO’^^ M, with a receptor density of 1 0 .6fmoles/pg of
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Figure 3.1
The displacement of -glutamic acid by excess cold L-glutamic
acid
B O U N D  G L U T A M A T E
c.
ig
i
a)
b)
c)
A semi-logarithmic plot showing the amount of 
[^H]-glu (I) bound to the membranes (as
disintegrations/minute) against the total concentration of 
glu added. Each point is the mean of 3-6 samples and 
the error bars give the standard error about this mean.
A Scatchard plot using data derived from the results 
graphically displayed in figure 3.1(a). The non-specific 
binding was taken as that amount of [ H]-glu bound 
in the presence of 10 cold glu. This was 911dpm 
for this experiment. 32pg protein were used per assay, thus 
the number of glu receptors present was 1 0 .6fmoles/pg
_7
of protein and the for glu was I.SAxlO M.
A Hill plot using data derived from the results of the 
Scatchard plot (Figure 3.1(b)). The slope of this line was 
1 .OA and the intercept on the x-axis -6.75 (giving a 
of 1.78x10“'^ M).
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Figure 3.2
The effect of Ha'*’ ion concentration upon the binding of glutamate to 
its receptor in membranes derived from P.americana CHS.
The points show the mean and the standard error about that mean, each 
point being assayed at least in triplicate. Each sample contained 
lOpg of protein.
dpm [^H]—Glutamate bound
1 10 
mM NaCI
100
0 - 0 Non-specific binding : radioactivity bound in the presence 
of 10”^M cold glu.
Total binding : radioactivity bound in the presence of the 
diluted ligand only ( A7.5nM glu).
» Significant difference.
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membrane protein. The two points at high ligand concentrations were 
not used in calculating these values. Such p>oints have been reported 
to give aberant results because the amount of 'specific binding' is 
too small to be statistically significant when compared with the 
amount of 'non-specific binding' or because of the presence of 
saturable non-specific sites of very low ligand affinity (Cuatrecasas 
and Hollenberg 1976). The slope of the Hill plot of 1.OA confirmed 
that the binding of L-glu to the membrane receptors was
_7
non-cooperative and that the was around 1.8x10 M, the plot giving 
a value of 1.78x10
The ion dependency of the binding of L-glu to its membrane receptors 
was studied, the various ions being added as concentrated solutions 
in place of the 20pl displacer. Figure 3.2 shows the effect of Na'*' 
(added as NaCl). The system was highly sensitive to Na''’, the amount 
of L-glu associated with the membranes increased some 8-10 fold with 
the addition of only lOmM NaCl. K'*’ (as KCl), Mg^ ''’(as MgSO.) and 
Ca^ ''’(as CaCl2 ) were all added at lOOmM and the results are given in 
Table 3.1 It is clear that none of these ions had any effect on the 
binding of L-glu to the membrane receptors.
Finally, the ability of various glu agonists and antagonists to 
displace the 'specific' component of the membrane bound glu was 
studied. The displacing compounds were added at a final 
concentration of 10 M and the percentage of the 'specific binding' 
displaced calculated. The results are given in Table 3.2. Of the 
compounds tested, D- and L-aspartic acid (II) and L-amino-adipic acid 
(III) are all potent displacers of the specifically bound component 
of the glu membrane binding, whilst 1-amino-1,2-dicarboxy-cyclobutane 
(IX) and dihydrokainic acid (XV) show no such ability. The other 
compounds listed fell into two groups:
a) those having scxne appreciable tendency to displace the 
specifically bound L-glu (N-methyl-L-aspartic acid (IV); 
2,6-dicarboxypiperidine (VIII); DL-APB (VI);
1-amino-1,3-dicarboxy -cyclopentane (X). These all displace some 60% 
of the specifically bound glutamic acid).
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Table 3.2
COKPOUliD NUMBER % SPECIFIC BIND 
DISPLACED BY 10
L-aspartic acid II 123+/- 4*
L-aainoadipic acid III 87+/-14*'
E>-aspartlc acid II 71+/-38*
N-nethyl-L-aspartic 
acid
IV 61+/-20*
piperidine-2,6-di- 
carboxylic acid
VIT/ 59+/-12*"
DL-ami nophospho- 
butyric acid
VI 58+/- 5*"
1-amino-1,3-di­
car boxy-cyclopentane
X 56+/-15*^"
D-aminoadipic acid III 46+/-22*
DL-2-ami nophospho- 
valeric acid
VII 44+/-22"
O-glutamic acid I 39+/- 5-*
1-amino-l,2-di- 
carboxy-cyclobutane
XI 6+/-51"
dihydrokainic acid XV 1+/-51"
2
The effect of various conpounds upon the amount of L-[ H]-glutamic 
acid specifically bound to P.americana central nervous tissue 
membranes.
Various putative glutamic acid agonists and antagonists were added to 
the membrane preparation at a final concentration of 10"^M. Their 
ability to displace the specifically bound L-glu (I) was measured by 
the percentage of that component displaced. The figures give the 
mean and standard error of at least triplicate samples.
X Significantly different to 0% inhibition (no added cold glu)
«3
+ Significantly different to 100% inhibition (10 M added 
cold glu).
-  68 -
BEThODiSECTIONi RADI0LI6AND DISPLACER N0N-S»ECIPICElhOlNB'dp»)
TOTAL
EIN0lN5(dpi
SnARIf fiSO RCEEf'S¡2.3.2)
D:-["n)-APB It*- Di-APB 567+/- 63 556+/- 12
•
♦2.S»f3iCU
• ft 505+/- 165 581+/- 47
•
♦CiCh/I-K
i ft 593+/- 56 565+/- 7
•
<iCli/20»C/ ¿0 iin
■ ft 623+/- 63 565+/- 7
E-iARI^ AND ROEERT; (2.2.3.1)
(’H)-Uinitacid Ik P kainic acid 3044+/- 224 3240+/- 833
• • L-giu 2953+/- 113 •
• • ]»« DL-APE 2979+/- 306 ■
:TAT! et i l  
C  3 3.2) C^ri)-ninitacid liB kainic acid 20807+/- 194 21137+/-3163
• 1 U S  L-glu 13479+/-3157 ft
• • DL-APB 18247+/-1972 ft
RJC* et i l
12.2.3.3) [^hj-rainitacid liP kainic acid 23470+/- 423 21577+/-3836
1 • lifl L-glu 23574+/- 748 ft
Table 3.3
;(
The binding of other putative glutamic acid receptor ligands.
[^H]-labelled APB (VI) and [^H]-labelled kainic acid (XI) were both 
used to try to reveal specific, displaceable binding of the glu 
receptor. Neither ligand proved useful, despite the use of various 
methods.
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%b) those for which the glu displacing ability was equivocal (W-amlno- 
adipic acid (III); 2-amino phosphovaleric acid (VII); D-glu (I);
¿i3placing some 40% of the specifically bound glu, but having 
standard arrors large enough for this not to be signicantly different 
to the 'total binding' control).
A brief study was also made on the binding of L-[ H]—glu to membrane 
fragments produced using Gray and Whittaker's sucrose step gradient 
(Section 2.3.1.1). This method gave more protein in the final pellet 
(75|ig) and specific, displaceable glu binding was clearly present 
(with no added cold glutamic acid the membrane fragments bound 15323 
¿767 dpm/; with lO'^M added cold glu they bound 1963 * 767 dpm). 
However, this was not a significant improvement on the shorter method 
of Sharif and Roberts and so it was not taken any further.
3.3.2
ligands.
The binding of other putative glutamic acid receptor
Various other glu receptor ligands were tried on various membrane 
preparations (described in Sections 2.3.2 and 2.3.3) and the results 
are given in Table 3.3. Neither D,L-[^H]-APB (VI) acid nor 
[^H]-kainic acid (XIV) were able to reveal specific, displaceable 
membrane binding, despite various modifications to the method (for 
kainic acid) or to the binding saline (e.g. by the addition of CaCl2 
in the case of APB).
3 . 4  The binding of ligands to the GABA/Cl channel complex
in membranes derived from P. americana central nervous tissue.
The results of these experiments are given below.
3 .4 , 1 The binding of ligands to the GABA (XVII) recognition
site (Section 2.A.1)
For the experiments investigating the binding of [ H]-GABA to Triton 
treated membranes, the samples contained between 30 and AOpg protein 
each. They showed that the 'non-specific binding' was between 30% ^ 
and 50% of the total radioactivity bound in the presence of 2.5x10 M 
GABA. With the standard error of the mean for each group of
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Figure 3.3
The graphical representation of the displacement of ['^H]-GABA by 
added cold GABA from membranes derived from P. americana central 
nervous tissue.
a) A semi-log plot showing the amount of [ H]-GABA (XVII) 
bound to the membranes (as disintegrations per minute) 
against the total concentration of GABA added. Each point 
is the mean of triplicate samples, the error bars giving the 
standard error.
b.
BOUND GABA (f moles)
b) A Scatchard plot using data derived from the results 
graphically displayed in Figure 3.3(a). The ’non-specific
3
binding' was taken as the amount of [ H]-GABA bound in 
the presence of 10 cold GABA - a value of 2779 dpm.
For this experiment, A5pg of membrane protein were used per 
assay. Thus the number of receptors present was 
22.9fmoles/pg protein and the was 1.18.10 ^M.
c) A Hill plot using the value for the number of receptors
present derived from the Scatchard plot given in Figure
3.3.(b). The slope of this line was 1.06 and the intercept
—6on the abscissa -5.98 (giving a value of 1.06x10 M).
-7 -6
Ig [GABA]
-5
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replicate samples being between 10% and 30% of the mean, this meant 
that many of the experiments performed showed no statistically 
significant displaceable binding of the [ H]-labelled GABA probe. 
However, it was possible to obtain Scatchard and Hill plots from some 
of these experiments, and Figure 3.3 shows one such example. These 
experiments showed the membranes to contain 16.1 - 6.8fmoles GABA 
receptor/|ig membrane protein. The K.^  values were 1.79 - 0.61 pM by 
the use of Scatchard plots and 2.01 * 0.96pM by use of Hill plots.
The Hill plots gave slopes between 0.95 and 1.06, confirming that the 
assumption on non-cooperativity made for the Scatchard plots was 
valid.
The use of [ H]-muscimol (XXI) in place of [ H]-GABA did not improve 
the low level of ’specific binding' obtainable, however, it did seem 
to reduce the variations within groups of replicate samples - the 
standard error being only 5% to 10% of the mean when using 
[■^H]-muscimol. A typical curve for the displacement of [ H]-muscimol 
by the addition of unlabelled GABA is given in Figure 3.A. This 
shows an apparent of 1.9x10 M.
To test the efficacy of various compounds sis GABA agonists and 
antagonists at the P. americana central nervous tissue GABA 
recognition site, [ H]-muscimol was used as the radioligand and the 
compounds added at a final concentration of 10 M. Of the 18 
compounds listed in Table 3.4, only five (piperidine-4-sulphonic acid 
(XXV); N(pyrimidin-2,4-dione-6-yl)-hydrazine (XXVII); aminopropane 
sulphonic acid (XVIII); N-(dodecyl)-2-hydroxy-benzylamine (XXVIII);
2,6-dicarboxypiperidine (VIII)) showed the ability significantly to 
reduce the amount of [^H]-muscimol bound. The other 13 compounds 
gave results that did not differ significantly from the amount of
3
[ H]-muscimol bound with no cold displacer present.
3.4.2 
channel.
The binding of radioligands directed at the Cl
[^H]-DPTX (XLIII), [^^S]-TBPS (XLVI) and [^H]-TB0B (XLVII) were all 
tried to no avail, as in no case was specific displaceable binding 
revealed. The results are given in Table 3.5.
dpm
Figure 3.A
3
The ability of cold GABA to displace membrane bound [ H]-muscimol.
This diagram shows the amount of ["^H]-muscimol (XXI) bound to 
membranes derived from P. americana CNS against the concentration of 
cold GABA added to the system. Each point represents the mean of 
triplicate samples and the error bars show the standard error about 
that mean. AOpg of protein were used for each sample. This
_7
displacement curve gives an apparent of 1.9x10 M.
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C0HP0UND NUHBER {SPECIFIC BINDING DISPLACED BY 10-=*N
piperidine-i'sulphonit acid nv 102+/-ir»
N-(pyniidin-2,4-dione"6-yl)-hydrazine
XXVII 8S+/-24*
1-aBinopro/««sulphonic acid XVIII 834/- T
N'-(dodetyl)-2-hydroxy-benzylaaine
XXVIII 644/-)6*
piperidine-2,(’dicarboxylic acid
VIII S04/-42*
antinophosphonovaleric acid VII 304/-36*
N-iethyl-L-aspartic acid IV 29+/-18*
L-a»inoadipic acid III 26+/- 7*
4-(aiiinopropyl )-3-hydrosy- 2-iethyl-pyrazine XXIX
194/-4r
5-(aiino»ethyl)-3-hydroxy- pyrazine
XXX 184/-36*
3-(piperidin-S-yl)-propionic acid.HCl XXXI 124/-12*
3-aiinoethyl-pyridine.HCl XXXIII n+/-26*
3-phenyl*4’aninobutyric acid XXXVII 84/-14*
ethyl-2-(p-chlorobenzyl)-3-(piperidin-6-yl)-propionale XXXII 14/-19*
2-(piperidin-S-yl)-ethyl- sulphonic acid XXXIV - 34/- r
nipecotic acid XXVI -144/-36*
2-phenyl-4-hydroxy-6- aiinoiethyl piperidine.HCl XXXV -154/-27*
3-hydroxy-6ASA XIX -244/-18*
Table 3.A
The ability of various compounds to displace [ ^ I h d u s cIhioI.
The results obtained by adding various compounds to a preparation of 
membranes displaying specific [^H]-muscimol (XXI) binding. The 
compounds were added at 10“^M and the percentage of the specific 
[^H]-muscimol binding displaced calculated. The table gives the 
results as the (mean) * (standard error) of at least triplicate 
samples.
X Significantly different from 0% inhibition (no added cold 
GABA (XVII)). _3
+ Significantly different from 100% inhibition (10 M cold 
GABA added)
Also tested at 10"^M, when it gave the result of 
5 - 2 1 %  which is not statistically different from the 
value with no added compound.
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HETHOD(SECTION) RADIOLIGAND DISPLACER
NON-SPECIFICBINDIN6(dpa) TOTAL BINDING ' ^(dpi)
OLSEN et i l  
(2.4.2.1)
I’HI-DPTX 10-*n PTX 14088+/-1177 107584/- 772 1
RANANJANEYULU AND TICKU (2.4.2.2.1) [«SI-TBPS 10-=*H PTX
1
'dialysis 1 ■ 20S7*/- 260 23524/- 213 !
-washings ■ ■ 6369*/- 364 65774/- 218 ::
NICHOLSON et i l  (2.4.2.2.2) [“ S3-7BPS lO-’H PTX
unshotked •200iN KBr ■ H 686*/- 129 7034/- 37
-200aH NaCl ■ ■ • 5004/- 75
-200aH KCl ■ ■ • 5044/- 2 i
-200m KI • ■ t 5144/- IS j
shocked -200in KBr • N 739*/- 13 6714/- 13 1
-200aN NaCl • H • 8494/- 107 11
-200bN KCl • ■ i 6674/- 44 Ìi
•200iN KI • ■ i 8184/- 82 j
RANANJANEYULU AND TICKU (2.4.2.3.1)
t*Hl-7B0B 10-*H PTX 16154/- 60
i
15964/- 217 1
!
LAURENCE et i l  (2.4.2.3.2) t’HI-TBOB 5.10-‘H TBOB 43564/- 202 54674/- 484 {
♦
Table 3.5
The displacement of various Cl“ channel ligands from binding sites on 
membranes derived from the central nervous tissue of P. americana.
Various methods were tried to reveal specific, displaceable binding 
of the c r  channel ligands [^H]-DPTX (XLIII), [^^S]-TBPS (XLVI) and 
[^H]-TBOB (XLVII). These are listed in this table, with the results 
given as the mean and standard error of at least triplicate samples.
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dpm
♦
Figure 3.5
3The binding of [ H]-GABA to membranes derived fran L.sericata.
This diagram shows the relationship between the amount of [ H]-GABA 
(XVII) bound and the total concentration of GABA present in 
experiments using the fly-head preparation described in 2.3.2.1.
Each point gives the mean and standard error about that mean for 
triplicate samples, each sample containing 0.1mg of membrane protein 
and 1.25x10^dpm of [^H]-GABA. The correlation coefWent for the 
derived Scatchard plot is only 0.31, this plot actually having a 
positive slope of 0.53.
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The method of Ramanjaneyulu and Ticku (Section 2.A.2.2.1) was also 
used to check the time course for the binding of [^^S]-TBPS to both 
mammalian and insect central nervous tissue derived membranes. The 
membranes were resuspended in binding saline containing 200mM KBr and 
incubated for up to 70 minutes, the displacing agent used being 10 M 
1-parabromopheny1-A-t-butyl-2,6,7-trioxabicyclo-[2,2,2]-octane 
(XLVIII). Whilst the mammalian (rat) membranes were showing maximal 
displaceable binding within 10 minutes (11A2 - 18 dpm with and A035 - 
5A6 dpm without added displacer), the insect (P. americana) tissue 
showed no displaceable binding at any time up to 70 minutes (when the 
values with and without displacer were 1AAA -19 dpm and 
1856 -20A dpm respectively).
3 , 5  The binding of ligands associated with amino-acid
coupled ion channels to membranes derived from other Insect tissue.
3 ,5 .1 , The binding of ligands to membranes derived from P^
americana coxal muscle.
k
;
i
)
None of the methods tried revealed specific, displaceable ligand 
binding for the [^^S]-TBPS (XLVI) experiment (Section 2.5.1.1). The 
amount bound in the presence or absence of 10 cold TBPS was 1052 
137 dpm and 750 • 106 dpm respectively. Even the denervation 
experiments showed no displaceable binding (Section 2.5.1.2). Thus 
the binding of [^H]-glu (I) to sarcoplasmic membranes (Section 
2.5.1.2.1) gave values with and without 10 M added cold glu of A21 
27 dpm and AA2 • 181 dpm for normal muscles and 212 - A dpm and 226 - 
75 dpm for denervated muscles. Likewise, the results for the binding 
of [^H]-muscimol to membranes prepared by the method Sharif and 
Roberts (Section 2.5.1.2.2) gave the following values when 10 M cold 
GABA (XVII) was either present or absent: 1A79 - 170 dpm and 15A2 - 
51 dpm for normal muscle and 1072 - 20 dpm and 1165 - 86 dpm for the 
denervated muscles.
3.5.2. The binding of radio-labelled amino-acid to membranes
derived from the central nervous tissue of insects other than ^  
americana.
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3
3.5.2.1. The binding of [ H]-GABA to membranes derived from the
heads of the green-bottle fly L. sericata.
The heads were added to the homogenisation medium at a concentration 
of 60mg (or 20 heads)/ml and the final membrane suspension was made 
up at a protein concentration of 0.25mg/ml (the equivalent of 
50 heads/ml). From the initial experiments there was a clear 
indication of the presence of displaceable [ H]-GABA binding and so a 
curve was constructed to show the displacement of [ H]-GABA by the 
addition of extra cold GABA. The results of this experiment are 
graphically displayed in Figure 3.5. It was then clear that this 
preparation provided no improvement on the system using membranes 
derived from the central nervous tissue of P. americana and because 
of this, no further experiments were carried out on this preparation.
3.5.2.2 The binding of [^H]-amino acids to membranes derived
from the central nervous tissue of the locust L. migratoria.
Both the ?2 and the produced by the method described (Section
2.5.2.2) were used to try to reveal specific, displaceable binding of
the [^H]-labelled amino acids L-glu and GABA. It was found that both
the ?2 and the P^ did display such binding, but in neither case was
the amount of displaceable binding seen in the P^ a significant
improvement upon that seen in the P«. Thus for L-glu the amount of
^ -3radioactivity bound in the presence or absence of 10 M cold L-glu
was 2905 ^ 93 dpm/100|ig protein and 5A78 i 389Í^protein for the
and 1857 - 19A dpm/100|ig protein and 63A6 • 1052 dpm/IOOpg protein
for the P-. The corresponding figures for the binding of GABA in the 
^ -3presence and absence of 10 M cold GABA were
I486 i 1A1 dpm/IOOpg protein and 2302 ~ 151 dpm/IOOpig protein for the 
?2 and 1595 - 222 dpm/100^lg protein and 1882 - 212 dpm/IOOpg protein 
for the P^. Because the extra work seemed to produce no improvement 
in the performance of the binding assay, this preparation was not 
investigated further.
a. P moles C02/mg wet weight tissue/min.
Figure 3.6
The properties of GAD derived from P. americana centrsQ. nervous 
tissue.
This figure graphically displays the effect of various parameters
14upon the production of CO2 (as measured by the amount of C trapped 
on the hyamine wick) from radiolabelled L-glu (I) by the enzyme GAD 
produced from P. americana CNS. Each point represents the mean of 
replicate samples, the error bars, where they fall outside the 
representative point giving the standard error about that mean.
b.
mg wet weight CNS
c.
a) The effect of pH upon the production of CO2 . The 
maximum activity was obtained at pH 6.9 and was 48.75 
- 0.40pmoles C02/mg wet weight CNS/min.
b) The effect of enzyme concentration upon the production of 
CO2 . This gives a linear relationship with a very good 
fit, the slope of the line being
44.40pmoles C02/min/mg wet weight CNS.
c) The effect of time of incubation upon the production of 
CO2 . This gives a linear relation with a very good fit, 
the slope of the line being 33.70 p moles C02/mg wet 
weight CNS/min.
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3.6 The results from the study of the enzyaes involved in
the production and degradation of GABA in P. americana central 
nervous tissue.
3.6,1 The properties of GAD derived from the central nervous
tissue of P. americana.
Figure 3.6 shows the effect of pH, enzyme concentration and
14
incubation time at 37®C upon the production of CO2 from
L-[u-^^C]-glu (I) by the enzyme GAD as prepared from the central
nervous tissue of P. americana. The pH curve shows a distinct
maximum at pH 6.9, with indications of a second maximum in the region
14of pH 7 .6  - pH 7 .8 . The rate of production of CO2 at the pH 6.9 
maximum was 48.75 - 0.40pmoles C02/mg wet weight tissue/min with a 
glu concentration of 5mM. This value for the pH was used for the 
subsequent investigations.
f
I
14Linear relationships were found between the production of CO« and
14the amount of enzyme used and the production of CO2 and the period 
of incubation. Between 1.2mg wet weight tissue/assay and 
11.2mg/assay, ^^C02 was produced at a rate of 44.40pmoles/mg/min in 
the presence of 5mM glu. The standard assay conditions of 5.6mg wet
14CO2 wasweight tissue/assay fitted nicely in this range. Likewise, 
produced at 33.70pmoles/mg/min at incubation times between 10 and 60 
minutes in the presence of 5mM glu. The standard assay was incubated 
for 20 minutes.
Figure 3 .7  shows the relationship between substrate concentrations 
and the rate of production of ^^€62 by this preparation of GAD. From 
this raw data, the Eadie plot was calculated (Eadiej 1942). From 
such plots for replicate experiments, the Vmax for this preparation 
was found to be 88.52 ~ 25.88pmoles C02/mg wet weight tissue/min, 
whilst the Km for L-glu was found to be 12.35 - 0.07mM.
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V p moles C02/mg wet weight CNS/min
i
♦
Figure 3.7
Calculating the Vmax and Km for GAD derived from P. americana central 
nervous tissue.
a) A plot of rate of production of CO2 against glutamic
acid concentration for GAD derived from P. americana. The 
points give the mean of replicate samples and the error bars 
the standard error about that mean.
b) An Eadie plot derived from the same data as that used in 
Figure 3.7(a). From this the Vmax is 125.1Ipmoles C02/mg 
wet weight CNS/min and the Km is 12.25mM.
The Eadie plot is derived from the Michaelis-Menten equation 
as follows
V = Vmax [S]
[S] + Km
from which:
V = Vmax - Km V/[S]
Thus a plot of V vs V/[S] will have L slope of -Km, and an 
intercept on the ordinate of Vmax.
- 81 -
Table 3.6
The fractionation of GABA-T derived from P. americana central nervous 
tissue.
The absolute and specific activities of various fractions sampled 
during the preparation of GABA-T from the central nervous tissue of 
P. americana. In each case, 50pl of the fraction (for P^, the pellet 
was resuspended in 0.5ml buffer) were incubated with the reaction 
medium for 30 minutes at 37°C.
SA«PLE 6ABA-T ACTIVITY-1 pnoles 6A6A/S0uI PROTEIN-IIug/SOuI SPECIFIC ACTIVITY I/Il COflPARATIVE ACTIVITY paoles 6ABA/CNS
S. 1364 93.5 14,58 1091
S: 794 22,5 35.27 1392
$3 491 10.0 49,10 1291
P3 230 15.0 15.30 252
>
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3.6.2 The properties of GABA-T derived from P. americana
central nervous tissue.
The background for the GABA-T studies was obtained using a blank 
assay which contained no enzyme. This gave a result of 1200 - 100 
dpm. This compared well with the typical enzyme incubations which 
were found to contain AOOO-6000 • 200 dpm. Assay samples lacking
2-oxoglutaric acid or containing ImM aminooxyacetic acid gave levels 
of radioactivity statistically indistinguishable from the no-enzyme 
blanks, indicating that the increase in radioactivity seen on adding 
the enzyme fraction was due to the breakdown of [^^C]-GABA (XVII) by 
the enzyme GABA-T.
Initially, 50pl samples of and (resuspended in 500jxl
buffer) were assayed for their GABA-T activity and their protein 
content. From the results (given in Table 3.6) it was clear that the 
use of gave the best combination of enzyme specificity (in terms 
of [^^C]-GABA converted/mg of protein) and total activity (in terms 
of [^^C]-GABA converted/50|il homogenate). For this reason, the S2 
fraction was the one used to study some of the properties of the 
enzyme.
The effect of temperature, incubation time, and enzyme concentration 
upon the activity of this preparation of GABA-T were all studied 
using the $ 2 and the results are graphically displayed in Figure 3.8. 
There was seen to be a clear temperature optimum at 37°C, where the 
rate of conversion of [^^C]-GABA to its products (initially succinic 
semi-aldehyde) was 2.59 - 0.10pmoles/pg protein/min. The 
relationship between the conversion of [^^C]-GABA and incubation time 
or enzyme concentration were both found to be non-linear, the tail 
off in these lines probably being due to a limiting concentration of 
either 2-oxoglutaric acid or GABA.
Figure 3.8
Various properties of GABA-T derived fro« P. aaericana central 
nervous tissue.
The graphs in this figure show the relationship between the total 
amount of [^^C]-GABA (XVII) converted by GABA-T and various of the 
reaction parameters. Each point represents the mean of 3 replicates, 
with the error bars showing the standard error (if this falls outside 
the representational point).
a) The effect of time upon the breakdown of GABA.
b) The effect of temperature upon the breakdown of GABA.
c) The effect of enzyme concentration upon the breakdown of 
GABA.
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3,6,3 The effect of various compounds upon the level of GABA
within the CNS of P, americana.
The three synthetic compounds 2-dimethylaminophenylacetonitrile (DAPA 
-XXXVIII), /-vinyl-GABA (XXXIX), ¿T-acetylenic-GABA (XL) were tested 
for their effects upon the level of GABA within the CNS, The results 
are given in Table 3.7. DAPA was found to decrease the GABA levels 
by a small and statistically non-significant amount, whilst 
y-acetylenic and ii-vinyl-GABA both significantly increased the levels 
of GABA. This was not too surprising, as both the latter compounds 
are potent inhibitors of GABA-T.
3 ,7  Studies into the release of radioactivity by
synaptosomes derived from the central nervous tissue of P. anericana.
Various compounds, mostly known or putative modulators of the 
GABA/Cl" channel complex, were added alone or in various binary 
combinations, to investigate their ability to stimulate the release 
of radioactivity from synaptosomes produced as described in Section
2,7.
3.7.1 Calculations of results.
The results were calculated in terms of nmoles [ H] released/CNS 
equivalent (nmoles [^H]/CNS), this being the amount of radioactivity 
released due to the stimulating ability of the added ccxnpound and so 
the amount of radioactivity released above the basal (control) level 
of release. The control release was caused by a ccmibination of the 
washing out of extra-synaptosomal radioactivity and the release of 
small amounts due to the leakage or rupture of some of the 
synaptosomes resting on the filter bed.
This value was calculated as follows (see Figure 3.9 for an example):
1. The total radioactivity released (in cpm) from the control 
(C) and the test (T) channels was summated from one fraction 
before the addition of the test compound to the end of the 
experiment (n fractions).
Figure 3.9
A worked example of the calculation of results fixxn the study of the 
release of radioactivity frcxn synaptosomes derived from the central 
nervous tissue of p, americana.
The graph opposite shows the result of a typical experiment involving 
10“®M ivermectin: The calculation of the ivermectin induced 
stimulated release from these profiles is given below.
1. Released radioactivity was summated for fractions A to 11.
T = 20507 cpm 
C = 12017 cpm 
n = 8
2. C.S.R. = T-C = 8A90 cpm
3. F = nx = 8.350 = 2800 cpm
A. T.S.R. = C.S.R-F = 5690 cpm
5. The counting efficiency for this experiment was 38%,
Thus:
Total stimulated release = T.S.R x _1_
0.38 AA.A
= 337.25 fmoles [^H]/CNS
0 -0  Control 
—810 M Ivermectin.
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2. The crude stimulated release (C.S.R) was obtained by 
subtracting the control total from the test total.
3. A correction factor (F) was applied. This was required 
because the release profiles prior to the test compound 
induced stimulation did not superimpose, but ran closely 
parallel to each other. The correction factor was applied 
to account for this and give a true picture of the amount of 
radioactivity released due to the stimulating effect of the 
test compound. To obtain this factor, the difference 
between the test profile and the control profile at the 
initial fraction (x) was multiplied by the number of 
fractions used.
A. The true stimulated release (T.S.R.) was obtained by
subtracting the correction factor from the crude stimulated
release.
T.S.R. = C.S.R. - F.
5. For the final step, three factors needed to be known.
(a) the number of CNS equivalents per channel, which was 
always four.
(b) the activity of the [^H]-choline chloride, which 
was 80Ci/mmole.
(c) the efficiency of counting (E), which was between 30% 
and A0%.
To convert from cpm to dpm, the true stimulated release was divided 
the efficiency and to convert from dpm to fmoles [ H]/CNS, a 
factor of 1/AA.A was applied (as 1 mmole = 80x2.22x10 dpm) Thus.
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Total stimulated release = T.S.R. x 1 fmoles [ H]/CNS
E 4A.4
3 The effect of ivermectin, alone and in combination with
various GABA/Cl” channel effectors, upon the release of radioactivity
3
by superfusion from synaptosomes pre-loaded with [ H]-choline 
chloride.
>
These studies were undertaken to confirm and extend the work 
described by Nicholson et al (1986).
Ivermectin (LIII) is the 22,23-dihydro derivative of avermectin
B the naturally occuring product from the mould Streptomyces
la/lb
avermectllis. It was obtained by small scale extraction of the MSD 
Agvet product ’Ivomec'. Figure 3.10 gives a brief dose-response 
curve. Nicholson et al (1986) showed this compound to give a maximum 
stimulation of release of 116A.Afmoles [ H]/CNS, with an EC^q of 
1.09x10“^M. In the following experiments, 10“®M ivermectin was used 
to cause stimulation of release. This gave a stimulation of 652.9 - 
120.0fmoles [^H]/CNS, about 70% of the maximal stimulation.
—8Various compounds were tested in combination with 10 M ivermectin to 
see how they affected the ivermectin stimulated release. The results 
obtained are given in Table 3.8. None of the compounds tested were 
found to potentiate the response and the ones which were most 
effective at inhibiting the response were the putative Cl channel 
blockers such as PTX (XLII), dieldrin (XLIV) and lindane (XLV) (BHC). 
Of interest was the failure of TPBS (XLVI) to inhibit the ivermectin 
stimulated release, as it has been suggested that this compound is 
PTX like in its action.
All of the compounds tested with ivermectin were also tested on their 
own for their ability to perturb the release of radioactivity from 
superfused synaptoscnnes that had been previously loaded with 
[^H]-choline chloride.
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f moles [^H] /CNS
Figure 3.10
The effect of ivemectin upon the stimulation of release of 
radioactivity from synaptosomes pre-loaded with [ H]-choline
chloride.
A graph of the stimulated release caused by 10" M, 10" M 
jO”^M ivermectin (LIII): These results agree with 
those reported by Nicholson et al (1986).
COMPOUND
PTX
dieldrin
lindane
TBOB
GABA
TBPS
diazepam
UMBER CONCENTRATION %INHIBI'
(pM) IVERMECTIN
XLII I . 0 78
0. 1 29
XLIV 1.0 93
0.1 56
XLV 1.0 78
C . I 68
XLV 11 10.0 72
1.0 6
XVII 2000.0 1
500.0 0
XLV I 10.0 15
L 10.0 0
I
Table 3.8
The ability of compounds to inhibit the stimulation of release of 
radioactivity induced by 10“®M ivermectin.
Various compounds were tested for their ability to affect the 
stimulation of release of radioactivity by 10'®M ivermectin (LIII). 
They were added at the same time as the ivermectin, and the 
percentage inhibition of stimulated release calculated. None of the 
compounds were found to stimulate release. The results for dieldrin 
(XLIV), lindane (XLV) and PTX (XLII) broadly correspond with those 
reported by Nicholson et al. (1986).
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0 %
5 %
(a)
Table 3.9
F R A C T I C N [ ’^ q ] - B O U N D ( d p t )
2a^ vit h o u t  
n u c t i n e  n i c o t i n e
[ ’” n  S P E C I F I C A L L Y  
B O U N D ( d p a )
a)
¿2thl- 58 2 S 6 6 e + / - U 2 e 2 3 4 1 5 + / - 1 2 8 5
C .W A 3 5 8 W -  28 1 2 5 0 + / -  75 6 9 4 + / -  B8
Fi 5t 3 A 3 5 0 + / - 1 7 6 5 3 0 5 7 2 + / - 1 8 e 4
(b)
FRA CTION [ ’= M ] - 6 0 U N 0 P R O T E I N S P E C I F I C  A C T I V I T Y
/ h o l e s «9 £Koles/r«g
14 top 0 . 0 5 0 0,14 0,3 57
To d E. 0,031 0,06 0,571
li 0 , 0 3 3 0,02 1,650
: ' I . Bi 0 , 0 8 6 0,04 2,1 50
‘
•li 0 , 0 7 3 0,04 1,825
1 ^1 ^  ^
i ^  T D3 0,121 0,06 2,017
1 ^ 2 li 0 , 1 6 6 0,06 2,767
84 0,3 52 0,12 2,514
l4 0, 7 4 3 0,20 3,715
pellet 1,104 0,54 2,044
The binding of [^^^I]-bungarotoxin to membranes derived from 
americana central nervous tissue.
This shows the crude results obtained from the ,
and crude preparation. Specific, displaceable
['2^13-bungarotoxin binding was clearly seen in each 
fraction; the displaceable element being up to 90% of the 
total binding in the absence of cold nicotine added as a 
displacing agent. Each value gives the mean and standard 
error of triplicate samples.
The crude ?2 was further purified on a discontinuous 
Ficoll gradient containing bands of 0%, 5%, 7%, 9%» H %
(w/v) Ficoll. Each zone was tested for the ability to bind 
C^^^I]-bungarotoxin in a specific, displaceable manner. The 
results are given for the fmoles of bungarotoxin so bound 
and the amount of protein present in each zone.
Peilef
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All compounds were tested at 10"^M and at this concentration none 
were found to have any effect. Due to its higher solubility, GABA 
(XVII) was also tested at concentrations up to 2x10 M, At 10 M, it 
consistantly failed to cause any stimulation of release, but at 
2 x 10"^M it did cause stimulated release on one out of three 
occasions. The stimulation of release was at a level of 
2 5 9.0fmoles [^H]/CNS and this was inhibited by PTX (25% at 10 ^M) and
Miscellaneous experiments.
3.8.1 The binding of [^H]-nicotine to membranes derived from
the central nervous tissue of P. americana.
The binding of [^H]-nicotine to a synaptosomal preparation gave 
results very similar to those for [^H]-glu. Using 25ug of membrane 
protein per sample, with no added cold nicotine 920 i 128 dpm were 
associated with the membranes, compared with A02 • 32 dpm in the 
presence of lO'^M cold nicotine. This gave a displaceable binding 
component of 0.267 - 0.068fmoles/pg protein. The corresponding 
figures for [^H]-glu using the same preparation were 1360 - 59 dpm 
and 66A - 59 dpm for the membrane associated radioactivity in the 
absence and in the presence of excess added cold glu, giving a 
displaceable component of 0.A18 - 0.0A9fnioles/pg protein.
3.8.2. The binding of [‘'^^n-bungarotoxin to membranes derived
from the central nervous tissue of P. americana.
As well as assaying the various fractions of the step gradient for 
the ability to bind [^^^I]-bungarotoxin in a specific, displaceable 
fashion, samples of the , $ 2 and crude P2 were also assayed. 
Specific, displaceable binding was found in all the fractions tested
and the results are given in Table 3.9»
3.8.3. The metabolism of [ H]-TBOB.
Although TBOB is known to be an unstable ccxnpound in acid conditions, 
these experiments gave no evidence that the hydrolytic breakdown of 
the radiolabelled compound under the assay conditions in the presence 
of membranes derived from P. americana central nervous tissue was the 
cause of the poor results. Typical profiles for the optical 
density/radioactive content of the HPLC eluate of a test run and of 
an unincubated sample are given in Figure 3.11. The unincubated 
sample showed that 93% of the radioactivity co-elutes with the peak 
corresponding to TBOB. For samples incubated at A®C, 21 °C and 37°C 
the corresponding figures were 79%, 79% and 72%. There would appear 
to have been some degradation on incubation with the membranes, but 
this should not have been enough to have accounted for the failure to 
disclose specific, displaceable binding.
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uFigure 3.11
HPLC traces of [^]-TBOB,
Samples were run on a Chrompak - C^g reverse phase column with 70% 
methanol-30% water as the mobile phase. The optical density was read 
at 210nm and fractions were collected every minute for liquid 
scintillation counting Ipg of cold TBOB was added to each sample to
act as a marker.
a) 1pCi[^H]-TB0B (XLVI) was chromatographed to assay the 
purity of the stock solution. 93% of the radioactivity 
co-eluted with the peak corresponding to TBOB.
b) The elution profile for the sample which had been incubated 
at A®C 79% of the radioactivity co-eluted with the TBOB
peak.
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A.1 Ligand binding experiments
The ligand binding experiments undertaken in the present study are 
discussed below in the context of similar ones carried out by other 
researchers. It should be noted that, where techniques have been 
adapted from use in other test species (usually the rat), the 
protocol was followed on the original models prior to their use in 
the insect. Results similar to those quoted in the literature were 
obtained for all techniques except for the binding of DPTX (LIII).
A.1.1.
P.americana.
The binding of L-glu (I) to material from the CNS of
The material used in these studies has been shown to consist mainly 
of membrane vesicles. For the most part these are empty, but some 
contain general cellular debris, whilst others contain smaller 
vesicles. There is also some general cellular debris outside the 
vesicles. An electronmicrograph of this material is given in 
Figure A.1. The material used in the experiments on the GABA/Cl 
channel complex was found to be of a similar composition.
These membranes show two types of L-glu receptor, one independent of 
the presence of Na“^ ions and the other requiring the presence of 
these ions before it is revealed. The Na'*’ ion dependent receptor 
only requires low concentrations of the cation to produce the maximal 
binding of L-glu, this being attained between 1 and 10 mM. The 
number of these Na"^  ion dependent receptors is far higher than that 
of the Na'*’- independent receptors and it would swamp any attempt to 
study the latter in the presence of Na'*’ ions. It is likely that this 
receptor represents a carrier system for the removal of L-glu from 
the external medium around the putative L-glu neuroreceptor. Such 
carrier systems have been shown in locust muscle (Briley et al.. 
1982), roach muscle (Wright: 198A) and roach abdominal nerve cord 
(Evans: 1975), the L-glu being sequestered by the glial sheath close 
to the neuroreceptor site (Botham et al.: 1979)»
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I •
Figure 4.1
'^1
An electronlcrograph of the Baterial used in the studies of3
L-[ H]-glu binding to Bsterial derived fron the CHS of the cockroach 
P.americana.
(
♦
This is an electronmicrograph of part of the Pg^erived from the CHS 
of P .americana used in the current radioligand binding studies using 
L-glu (I) as the radioligand. The micrograph is at a magnification of 
16250X and shows the preparation to consist mainly of empty membrane 
bound vesicles. There is also considerable cellular debris, both 
within some of the vesicles and in the surrounding area. The 
preparation used in the study of the binding of GABA (XVII) and 
muscimol (XXI) was very similar.
V-empty membrane vesicle 
C-cellular debris
, a'« -t t
\
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An electromicrograph of the material used In the studies of
L-[ H]-glu binding to material derived from the CNS of the cockroach
P.americana.
This is an electronmicrograph of part of the «derived from the CNS 
of P.americana used in the current radioligand binding studies using 
L-glu (I) as the radioligand. The micrograph is at a magnification of 
16250x and shows the preparation to consist mainly of empty membrane 
bound vesicles. There is also considerable cellular debris, both 
within some of the vesicles and in the surrounding area. The 
preparation used in the study of the binding of GABA (XVII) and 
muscimol (XXI) was very similar.
V-empty membrane vesicle 
C-cellular debris
REFERENCE SPECIES TISSUE U
nK p»oles/ng pri
Biziere et j 7,;1960 rat brain 11.0 .
60.0 -
Honoré' et :1981b rat brain 509,0 13.0
820,0 54.5
Hichaelis et rat brain 60-70 70-130
208-295 208-381
Redburn;1981 rabbit retina 72,0 1.5
Verling and Nadler;1982 rat brain 11.0 2.5
570,0 47.0
Janes et i/.; 1977a S . g r e g e r i i »uscle 8000,0
50000,0 -
Janes et 1977b S . g r e g e r i i •uscle 530,0 25,0
Briley et i/,;1979 S . g r e g e r i i luscle 30000,0 52,0
Briley et a/. ;1981 S . g r e g a r i i luscle 12.5 0,57
1300,0 10,9
Filbin et ay.;1985 ñ. do te s  t i  a luscle 500,0 5-60
Current study P, i t e r  i  a m CN3 184,0 10,6
Table A.1
ir and B values for the post-synaptic L-glu receptors reported by 
*^ d nax
various workers.
Collated here are the values for the and of the post-synaptic
receptors for L-glu (I) reported by various workers. The species and 
tissue involved are given in each case. This collation is by no 
means comprehensive, but it does give an idea of the spread of values 
obtained. More comprehensive reviews of values obtained can be found 
in Briley et al. (1981 ) and Honore et al. (1981 a).
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The K and B of the Na"^  ion independent receptor, at I.BAxlO M (] max
and 1 0 .6pmoles/mg protein respectively, are compared in Table A.1 
with those for putative post-synaptic receptors reported by various 
other workers from both the mammalian and the insect fields of 
research. On the whole the values obtained in this study seem to fit 
in well with the general trend. Although many of the receptors 
described by previous workers have a higher affinity for L-glu than 
the one descibed here, they are balanced by ones with lower affinity 
and the variation between these sets of results is well within that 
which one would expect when comparing the work of researchers in 
different laboratories using supposedly similar techniques. Due to 
the vague nature of the experimental detail in many of the papers, it 
is often difficult to assess the exact nature of any differences in 
the techniques that were used. But even when the same techniques 
have been used by the same workers (eg. James et al. 1977a and 1977b) 
quite large variation in the observed affinity for L-glu may occur. 
There are exceptions at both extremes. All those giving very low 
affinities were early reports and these can be put down to 
insufficiencies in the technique in a pioneering field of work. At 
the other extreme are those high affinity sites reported by Biziere 
et al. (1980) and Werling and Nadler (1982) in rat brain and Briley 
et al. (1981) in locust muscle.
Despite the variation found in the apparent affinity of the receptor 
sites for L-glu, all these results do agree on the slope of the Hill 
plot. All these investigators found Hill slopes close to unity, 
indicating a lack of cooperativity in the binding of the ligand to
its receptor.
The overall variation in this set of results is so great that they 
provide no basis for making any firm conclusions about the nature of 
the receptor investigated in this study.
Besides Na"^ , none of the ions tested had any effect upon the rece;»tor 
binding of the L-glu. This is in contrast to certain workers (Baudry 
et al.t1981; Fagg et al.;1982) who have found that CaClg in mM 
concentations increases the binding of L-glu to rat brain^membranes 
by some three-fold and that the L-glu binding to these Ca /Cl 
sensitive sites can be displaced L-APB (VI). The work by Fagg et_al.
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(1982) suggests that it is the presence of the Cl” ion which reveals 
these sites and they have suggested that this response may be related 
to L-glu activated Cl" channels. These may be similar to the 
H—receptors discovered by Oration et al.(1979)» The absence of this 
response in the present study correlates well with the failure to 
reveal any specific binding of the radio-labelled ABP when that was 
tested on membranes prepared from roach CNS. From the current study 
it is not possible to say whether this absence of response is due to 
a lack of the appropriate receptors in this tissue, or the need to 
modify the conditions of the assay slightly. However, as this 
response does not seem to be part of the normal L-glu 
neurotransmitter response, its absence would in no way rule out this 
receptor as having neurotransmitter function in the insect CNS.
In trying to decide whether the receptor studied here is a candidate 
for an L-glu neuroreceptor in the insect CNS, it is necessary to 
compare its pharmacological profile with the standard receptor 
classes and the previous studies of binding characteristics of 
putative L-glu receptors. Table A.2 compares the characteristics of 
the displacement of specifically bound L-glu of the receptor studied 
here with those of two studies of the putative L-glu neuroreceptor in 
the rat brain. As can be seen, the insect receptor differs quite 
markedly from that described by Roberts and Sharif (1981). The 
response to both stereo isomers of the short-chain excitatory amino 
acid aspartic acid (II) is greater in the insect that in the mammal, 
whilst the response to the D-isomer of glu is less. The response to 
cis-cyclopentane glutamic acid (X) is also weaker in the insect than 
in the mammal. Against this both these receptors show very little 
sensitivity to N-methyl-D-aspartic acid (IV: see note ’b* on Table 
A.2) although the L-stereo-isomer does have moderate activity in the 
insect system. However, when the results from the study by Werling 
and Nadler (1982) are compared with those obtained in this present 
work, a much closer correlation is found in the rank order; this 
despite the large difference obtained in the value of the from the 
two studies. The first thing to note is that the rank order for both 
the high and the low affinity sites found by Werling and Nadler is 
the same - at least for those compounds which were tested in both the 
mammalian and the insect systems. Secondly, the rank order for the 
receptor of Werling and Nadler and that for the insect are the same
-  101 -
COUPOUNO NUMBER INSECT 
^inhibition 
by Im H
ROBERTS AND SHARIF 
IC(o(pn)
VERLIN6 AND NADLER 
ICbo(pfl) 
high low
L-aspartate 11 123 42.1 (6) 0.77 (2) 1.2
L-glu I 100 4,8 (1) 0.45,10-=*(1) 0,33
L-aainoadipate III 87 26,3* (4) 1.1 (3) 1.5
D-aspartate 11 71 138,0 (7) 8.2 (5) 13.0
N-aetnyl aspartate IV 61'^ inactive‘(8) — —
DL-RPB VI 58 25,6 (3) 11.0 (6) 15.0
♦/-cis-cyclopentane t 56 18,5 (2) . . .
glutaaate
D-aiinoadipate III 46 26,3* (4) 1.1 (3) 3.0
+/-2-a#inophosphono-VIl 44 . . . 27.0 (7) 56,0
valerate
D-glu I 39 28,8 (5) 7.6 (4) 9.8
dihydrokainate XV 1 inactive (8) •  • • • • •
Table A.2
A comparison of the results for the displacement of specifically 
bound L-glu obtained for membranes derived from rat brain and for 
those derived frcMn P.americana.
The Table only shows compounds which were tested in at least two of
the systems. The final concentrations of the radioligand
L-[^H]-glu (I) were:
current study - 50nM
Roberts and Sharif (1981) - 800nM
Werling and Nadler (1982) - 2nM (high affinity)
lOOnM ( low affinity)
The results are given as IC^q values in for those concerning 
mammals and as % inhibition of specific binding by ImM displacer for 
those concerning the insect. The compounds are given in declining 
order of potency for this present study, with the rank order for the 
other studies given in brackets beside the IC^q values, 
a: For the results of Roberts and Sharif, D,L-amino adipate 
was used
b: For the result on P.americana, the L-stereo isomer was 
used, NMDA was tested, but this compound failed to give 
consistant results. The indications were that it was 
inactive.
c: For the result of Roberts and Sharif, the 
D-stereo isomer was used.
Ml’
J tí
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except for the D-isomer of glu. This mismatch with D-glu is not 
unexpected when it is remembered that D- and L-glu are roughly 
equipotent in mammalian electrophysiological systems, whilst D-glu is 
virtually without effect in insect systems.
No other studies showing the specific binding of L-glu to insect CNS 
material seem to exist, and few using the binding of this ligand to 
muscle preparations are available. The original work undertaken by 
James et al. (1977a and b) on a proteolipid extracted from locust 
muscle can hardly be used as a comparison, as they used L-[ C]-glu 
as the radioligand and described the specific binding as that 
component displaceable by high concentrations of cold D-glu.
However, work has recently been carried out by Filbin et al. (1985) 
on a membrane extract from housefly thoracic muscles. As in the 
current study, this showed L-aspartic acid to be very active as a 
displacer of specifically bound L-glu, and D-glu to show moderate 
activity (ImM displacing 61% of such binding). Against this, they 
showed N-methyl-D-aspartate to have similar activity to that of 
D-glu, whilst the L-stereo isomer and D-aspartic acid showed little 
or no activity. Whether this reflects a true difference between the 
putative L-glu synaptic receptors for the muscle and the CNS, or 
whether one or both these receptors are not what they are claimed 
cannot be decided at this point.
These responses do not easily fall into classification as any of the 
three types of excitatory amino acid receptor commonly discussed. 
Binding L-glu with moderate affinity, they are clearly not of the 
kainate-type, as these are now generally accepted to be separate 
entities. However, they are clearly not of the HMDA-type either. 
Not only do they seem to show a low affinity for this compound, but 
they also have a low affinity for the two standard antagonists at 
this type of receptor - namely amlnophosphonovaleric acid (VII) and 
D-amlnoadlpic acid (III). Neither are they simple quisqualate-type 
receptors, as L-aspartic acid is highly potent at the site revealed
in these studies.
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In general L-stereo isomers are more active than the corresponding 
D-stereo isomers. Thus the L-isomers of aspartic acid, 
N-methyl-aspartic acid and amino-adiptic acid, as well as of glu, 
show activity that is greater than their D-isomers. Further, 
comparing D,L-APB and D ,L-aminophosphonovaleric acid with L-glu and 
L-aminoadipic acid suggests that the carboxyl analogues are more 
effective as ligands for the receptor sites than the corresponding 
phosphono compounds - especially as D ,L-aminophosphonovaleric acid is 
less potent than the D as well as the L-isomer of aminoadipic acid. 
This suggests a receptor with considerable latitude in the size and 
shape of the compounds it will accept. As for the confirmation 
adopted by the ligands at the receptor site, the moderate activities 
of p ip e ridine-2 ,6-dicarboxylie acid {VIII) and cis-cyclopentane 
glutamate with the lack of activity of
1 -a m in o -1,2-dicarboxycyclobutane (XI) suggests that the two and three 
methylene amino acids (ie L-glu and L-aminoadipic acid) bind in a 
tightly folded configuration, whilst the one methylene amino acid 
(aspartic acid) binds in an extended confirmation. This differs 
slightly to the partially folded confirmation suggested by Usherwood 
(1981) as being the major receptor at the nmj in locusts.
Although it is not possible at this stage to show conclusively that 
the receptor site studied in these experiments is the neuroreceptor 
for L-glu in the insect CNS, various factors suggest that this may be 
the case. For these studies have revealed a receptor showing an 
affinity for L-glu that is well within the range expected for a 
neuroreceptor, that is Na"^  ion independent and that has an 
appropriate profile for the compounds that are active in displacing
L-glu.
A . 1 .1.1 other insect receptors for L-glu and related compounds.
The discovery of specific binding for L-glu in the CNS of locusts as 
well as in the cockroach suggests that the presence of L-glu as a 
central excitatory transmitter is widespread in insect species. 
However, on a superficial look at these receptors, they offered no 
advantages over that found in the cockroach for the general study of 
the insect CNS L-glu neuroreceptor.
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The failure of kainic acid (XIV) and APB to show any specific binding 
was interesting. In the case of APB this was not unexpected - the 
failure to reveal extra L-glu sites on the addition of Cl and the 
relatively low ability of APB to displace L-glu from its receptor 
both suggested that this could happen. The failure to obtain 
specific binding of kainic acid was not too surprising. Although it 
is toxic to insects (LD^q for L.sericata of 20pg/fly) it appears to 
act at the peripheral nmj rather than at the CNS, as it does in 
mammals (R.P. Botham, personal communication).
The failure to obtain the binding of L-glu to either normal or 
denervated muscle tissue came as some surprise, as such receptors 
have been found in both locust (Briley et al.t 1979) and housefly 
(Filbin et al.t 1985). Both these studies have used the thoracic 
musculature. It is quite possible that the use of the coxal muscle 
in this study has some bearing upon the failure to notice such 
receptors, as this muscle provides less material than the thoracic 
muscle and may also be innervated to a lesser degree - the thoracic 
muscle includes the flight motor system and this is quite heavily
innervated.
A.1.2 The binding of radioligands to the GABA/Cl channel in the 
insect CNS.
In contrast to the binding of L-glu and its putative insect 
neuroreceptor, considerable work has been undertaken in the study of 
the binding of ligands to their receptors in the GABA/Cl' channel 
area in insects and other arthropoda - particularly in the binding of
ligands to the Cl" ionophore.
A. 1.2.1 The binding of GABA and muscimol to a putative GABA
neuroreceptor in the CNS of P.americana.
These studies revealed a single class of Na* ion concentration 
independent receptors for GABA (XVII) in membranes derived from the 
CNS of the cockroach P.anerlcana. The of these receptors was 
I.IBpM, with a density of 2 2 .9pmoles/mg protein, and a slope for the 
Hill plot of close to unity - suggesting that these receptors are 
non-cooperative in their mode of action. Although these values are
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similar to the ones reported above for the putative receptor for 
L-glu, values that were well within the normal range for such work, 
they are higher than the values normally associated with 
GABA-neuroreceptors, as can be seen from Table 4.3, where some 
examples from both the mammalian and the Insect fields of study are 
given. The high values found In this study may be caused by the 
failure to remove all of the putative endogenous GABA-receptor 
modulator •GABA-modulin* (Mazzari et al.;1980), although some of the 
very low values may be spurious, a factor which must be b o m  in mind 
in the light of a comment made in the poster presented by Lunt et_al. 
(1984) to the effect that the specific binding was very low in 
relation to the total, being only "10-30% but occasionally zero."
The differences between the electrophysiologlcally and the 
biochemically derived values for the Hill plot are probably caused by
one of two reasons:
a) the binding of the radioligand in the biochemical experiments is
to an inactivated form of the receptor having a high affinity 
for GABA. This certainly happens in the binding of acetyl 
choline to the nicotinic receptor (Weber et_al.: 1975) and 
such a mechanism would explain the low values of the when 
these are compared with the concentrations needed to produce 
effects in the electrophysiologlcal experiments.
b) The interaction of the ligand with the binding site invlvo is
truly non-cooperative, but more than one receptor-ligand 
complex is needed to activate the ion channel.
Until the channel is isolated and broken down into its component 
parts, it will be difficult to decide between these two options.
The interactions of various GABA/Cl" channel effectors with this 
receptor were studied by measuring the displacement of specifically 
bound [^H]-musclmol (XXI). This compound is generally accepted as a 
specific GABA agonist and is frequently used in radioligand studies 
in place of GABA because of its higher affinity for the GABA site in 
the mamnalian CHS. There it is reputed as having an affinity for the 
neuroreceptor site ten-times greater than GABA. However, in two
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4- I,
i^EFERENCE S P E C I E S T I S S U E COriPOUND K d B » a  •n H p n o l e s / R g  p r o t e i n
rieiners e i ¿ 7 , 0 5 7 9 ) c r a y f i s h l u s c l e « u s n a o l 9 , 4 5 0 3  f » o l e s / g  f r e s h
Lunt et ¿ 7, (1954 ) ft.doeesticê C N S BABA 4 2 , 0 —
e r e e r  ¿nd L , a i g r i  to r iè C N S BABA 100 2 . 2
H e i l g e n b e r g ( 1 9 8 5 )
L u M i s  a n d  S a t t e l l e F . i a e n a m C N S BABA cíS4 1
(1955)
L u n l  et ¿7, ( 1 9 8 5 ) S . g r e g i r i i C N S n u s c i a o l 1 0 , 0 0 . 0 6
f l.d o ae st ic i C N S A u s c i a o l 4 0 , 0 0 , 0 2
Enna and S n y der rat b r a i n BABA 3 7 0 0 . 6 8
(1975)
S c h a e f f e r ( 1 9 8 0 ) rat r e t i n a R u s c i a o l 4 . 4 0 , 1 8 5
1 2 , 3 0 , 4 9 7
J o r d a n  et ¿ 7, (1582 ) rat b r a i n BABA 2 0 , 0 0 , 4 8
165 6 . 0
• u s t i a o l 1 .7 5 0 , 8 4
1 7 . 5 4 . 8
Cur r e n t  st u d y F . i a e r i a n i CN3 BABA 1 18 0 2 2 , 9
Table A.3
Values obtained for the and of the binding of GABA and
muscimol to tissue samples from mammalian and insect sources.
This table shows the values obtained for most of the studies into the 
insect systems, with a few representative examples from the mammalian 
field for comparison.
% •
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cases in which the displacement of [^Hl-GABA by muscimol has been 
studied in insect CHS membranes that latter compound was found to be 
less active. The values for the displacement of specifically
bound GABA given by Lummis and Sattelle (1985) were 130nM for GABA 
and 710nM for muscimol, whilst Breer and Heilgenberg (1985) found the 
K for GABA to be lOOnM and the IC^g for muscimol to displace that 
G m  to be 90nWI There is also some doubt about its specificity, so 
that care must be taken in its use. Thus, de Feudis and his team 
have shown differences between the behaviour of the two ligands as 
regards numbers of sites and response to sera from patients with some 
neuropathologlcal disorders (de Feudis et ■ 1979, Geffard et_al.: 
1979). Herschel and Baldessarinl (1979) showed a differential effect 
of Triton treatment between the two compounds and Breer and 
Heilgenberg (1985) have shown muscimol to inhibit the uptake of 
endogenous GABA into synaptosomes almost as efficiently as the 
standard GABA uptake inhibitor dl-aminobutyrlc acid (XX). Using the 
current system, the ICj q for the displacement of muscimol by cold 
GABA was 109nM. This compares with values of 125nM (Melners et 
al.*1979), and lOOnM and AOnM (Lunt et al.i 1985).
These results agree with others working on the GABA neuroreceptor in 
the insect CHS in that it is clear that the receptor studied in this 
work is like neither the mammalian GABA^ (bicuculllne 
(XLI)-sensitlve) nor the mammalian GABAg (baclofen (XXXVI)-sensitive) 
receptors. Thus whilst the GABA^ agonists piperldlne-A-sulphonic 
acid (XXV) and 3-aminopropane sulphonlc acid (XVIII) show good 
activity in this system, 3-hydroxy-GABA (XIX), a compound having 
reasonable activity in the mammalian GABA^^ system, is totally devoid 
of activity in this system. Likewise, 3-phenyl-GABA (XXXVII), whilst 
not the best displacer of specifically bound baclofen, does have 
reasonable activity in the GABAg system, but shows none in this one. 
However, there is also little agreement in the exact displacement 
profile of the insect CHS GABA receptor. Thus, whilst this study 
makes piperdine-A-sulphonlc acid and 3-a»inopropane sulphonlc acid 
highly active at the Insect site, Lunt et al.(1985) make
3-amlnopropane sulphonic acid orders of magnitude less potent than 
GABA. Luamls and Sattelle (1985) not only agree with this 
assessment, but also make piperidine-A-sulphonic acid totally 
inactive. On the whole, the results obtained in the present study
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Table A.A
cor.POUNO NUMBER {DISPLACED by 1 *M
LUHHIS AND 
SATTELLE 
ICso-pH
LUNT 
et al
IC»o-)iH
6ABA* SABA» 
ICso-pN ICsS0-|iH
piperidine-4- 
sulphonic )cid
m 102 inactive
(3)
— 0.034
(1)
inactive
(4)
6ABA XVII 100 0.13(1)
0,04
(1)
0.12
(3)
0,08
(1)
S-aiinopropine 
sulphonic acid
XVIII 83 390
(2)
0.3
(2)
0.11
(2)
10
(2)
3-(piperidin-6-yl)- 
propionic acid.HCl
XXXI 12 • • • 110(5)
3-phenyl“l*ai'ino- 
butyric acid
XXXVII 6 . . . •  • • 10(2)
2-(piperidin-6"yD- 
ethyl sulphonit atid
XXXIV -3 — 3500(6)
nipecotic acid XXVI - U inactive >100 (3) (3)
inactive inactive 
(7) (4)
2-hydroxy-5ABA XIX -24 — — 0.6(4)
1.13
(3)
A comparison of the IC^q values obtained for the displacement of 
^3u ]«q/^A by various compounds in different test systems.
The following results are taken from Luimnis and Sattelle (1985) and 
Lunt et al. (1985). The values for the rat brain systems are given 
in Lummis and Sattelle (1985), although some extra information has 
been obtained from Breckenridge et al. (1981) for the GABA^ site and 
Bowery (1982) for the GABAg site.
The values quoted from the other works are for IC^q in terms of i^M. 
For Lunt et al. this is for the displacement of radiolabelled 
muscimol (XXI), whilst for the others it is for the displacement of 
radiolabelled GABA (XVII). The values for the present study are for 
the % of the specifically bound radiolabelled muscimol displaced by 
ImM cold compound. The compounds are given in order of activity at 
the receptor sites revealed in this study and the rank orders for the 
other studies are given in brackets below the appropriate values.
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have disclosed a receptor that is closer in its profile to the 
mammalian GABA^ receptor than to anything else. These comparisons 
are laid out clearly in Table A.4.
A.1.2.2 The binding of [^H]-muscimol and [^H]-GABA to other insect 
receptors.
The presence of specific Na"*" ion concentration independent GABA 
binding to tissue derived from the CNS of both L.migratoria and 
L.sericata helps to confirm the presence of such putative GABA 
neuroreceptors over a wide range of insects. However, as these sites 
offered no clear benefits over the roach receptor in terms of amount 
of binding present or the ease of preparation of material, they were 
not followed up.
The failure to find specific binding of radiolabelled muscimol in 
roach coxal muscle membranes was not too surprising. The binding of 
ligands to the GABA receptor site (as opposed to the Cl” ionophore) 
in such preparations has not been reliably found. Thus Briley et al. 
(1982) commented that the binding of GABA had been difficult to 
measure.
A.1.2.3 The binding of ligands directed at the Cl" channel to
membrane preparations from the muscle and the CNS of P.americana.
The failure to show the binding of the Cl" channel directed ligands 
to either CNS or muscle membranes was disappointing. Thus no 
specific binding was found for [^H]-DPTX(XLIII) or [^H]-TBOB (XLVII) 
in the CNS, and none was found for [^^S]-TBPS (XLVI) in either the 
CNS or the muscle preparations.
The failure in the case of [^H]-DPTX was not too surprising, as there 
have always been problems with the high levels of non-specific 
binding with this ligand. Thus Tanaka et al. (198A), a group with 
much experience in the use of this ligand, studied its binding to 
membranes derived from the CNS of P.americana. They quoted the level 
of specific binding of DPTX in the fraction giving the best binding 
characteristics as being 1783- 66 dpm/mg protein, whilst the total 
binding was only 16688^104 dpm/mg protein - a specific binding
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content of just over 10%. Such low levels of specific binding are 
very difficult to work with, and are of questionable validity.
In the case of [ S]-TBPS, the failure to find specific binding in 
CNS tissue can be seen as confirmatory evidence for the thesis that 
this compound does not act at a central site in the insect. This 
will be discussed further in relation to the results of synaptosomal 
experiments. However, the failure to uncover such binding in the 
muscle membranes is not so easily understood as such sites have been 
found in the thoracic muscle tissue of other insects (Cohen and 
Casida: 1985, 1986). As with the binding of L-glu to similar 
membranes, the lack of binding may be due to a low level of 
innervation to the coxal muscles when compared with the thoracic 
muscles which are normally used to produce the membranes for use in 
binding studies in the insect muscle tissue.
Nor was it possible to uncover specific binding of the ligand 
[ H]-TB0B to the membranes derived from the CNS of the roach. This 
newly available ligand is believed to bind at the same site as TBPS 
and DPTX (Lawrence et al.: 1985), but being less polar should have 
more chance of crossing any lipid barriers that may protect the 
insect CNS. Further, unlike TBPS, it is active in the synaptosome 
system discussed below. Investigations carried out to assess whether 
the ligand was being degraded under the experimental conditions 
failed to find any evidence for the metabolism or degradation of the 
TBOB in these conditions. It is possible that, being far less active 
than PTX (XLII) at the blockade of the Cl” ionophore (this is so both 
chemically - see the work on the synaptosomes below; and 
electrophyslologically-G. Lees, personal communication), this ligand 
does not possess a high enough affinity for that site to be of use in 
the study of the insect receptor.
^.1.3 The binding of ligands to a putative acetylcholine receptor 
in material derived from the CNS of P.amerlcana.
The goal in any study into receptor biochemistry is the isolation and 
characterisation of the receptor protein complex, ultimately leading 
to the reconstruction of that receptor from its component parts.
This aim has been largely achieved with the nicotinic acetylcholine
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receptor from Torpedo mamorata, the work being greatly aided by the 
use of the snake venom o«-bungarotoxin (BTX). A receptor site bearing 
many similarities to the nicotinic receptor has been found in the 
nervous system of the housefly, M,domestics (March et al.t 1980).
9 '
When the nervous system of the cockroach was tested for its ability 
to bind specific binding of this ligand was clearly
demonstrated - not only in the purified fractions that were enriched 
in synaptic membranes, but also in all the other fractions, including 
the crude homogenate. The ability of [ H]-nicotine was then tested 
for its ability to reveal these sites. It was found that this 
ligand, which has an affinity for the acetylcholine receptor very 
similar to that of L-glu for its receptor, gave results that were 
qualitatively and quantitatively very similar to those obtained with 
L-glu in the studies described above. It would thus seem reasonable 
to conclude that little further progress will be made in studying the 
insect L-glu and GABA receptor sites until the discovery of a ligand 
for these sites bearing properties similar to those shown by BTX for 
the nicotinic acetylcholine receptor.
A.2 Studies using synaptosomes derived fron the CNS of
P.amerlcana
In the study of the biochemistry of the mammalian nervous systems, 
much use has been made of transmitter release and radiolabelled ion 
fluxes from synaptosomes (e.g. the study of radiolabelled sodium 
fluxes to study the action of the pyrethroid insecticide; Soderland 
and Ghiasuddin: 1985). These pinched off nerve terminals possess 
many of the properties of the parent structures and are readily 
available for biochemical manipulation. Such preparations are now 
also available for insects (for locusts see Breer and Jeserich: 1980; 
for cockroaches see Nicholson et al.: 1985). The system developed by 
Nicholson et al. vas used in this study, an electron-micrograph of 
the material present in this preparation is shown in the 
introduction.
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Perfusion of synaptosomes previously loaded with [ H]-choline with 
the macrocyclic lactone ivermectin (LIII) was found to cause a 
stimulation of the release of radioactivity (Nicholson et_al.:1986), 
part of this stimulated release consisting of tritium labelled 
acetylcholine (Nicholson, personal communication). There is 
considerable evidence to suggest that the mode of action of 
ivermectin in insects is by pertubation of the GABA/Cl" channel 
complex (for recent work see Duce and Scott: 1985; Tanaka and 
Matsumura: 1985; Wright: 1985). The ability of certain Cl" channel 
blockers, such as PTX (XLII), lindane (XLV) and dieldrin (XLIV), to 
block the stimulatory action of ivermectin on insect synaptosomes 
(Nicholson et al.:1986) suggested that this would be a good system in 
which to study various GABA/Cl” channel effectors. Work undertaken 
with dieldrin, lindane and PTX confirmed that the effects observed by 
Nicholson et al. were readily reproducable and the system was then 
used to study some of the other major GABA/Cl” channel effectors.
Of the compounds studied, the bicyclo-octane TBOB (XLII) was shown to 
have moderate activity in blocking the effect of ivermectin.
However, this compound was at least an order of magnitude less active 
than PTX and this low level of activity may account for its failure 
to reveal specific binding to the Cl” channel when used in the 
preparation discussed above.
None of the other compounds tested showed any appreciable ability to 
affect the stimulation of release of radioactivity caused by 
ivermectin. The negligable activity of TBPS, even at lOpM, lends 
weight to the argument that this compound acts at peripheral rather 
than central sites in the insect. This compound has similar binding 
parameters to TBOB in mammalian CNS preparations (Lawrence et 
:1985), in stark contrast to the differential effects found in 
this system. Of the two remaining ccxnpounds, neither GABA (XVII) nor 
diazepam (L) perturbed the effect of ivermectin in this system. This 
profile of activity in the synaptosome system correlates very well 
with toxicity data for these compounds obtained by the Applied 
Biology Section at the Wellcone Research Laboratories at Berkhamsted 
Hill. These showed LD^^ values for PTX, TBOB and TBPS to be 0.01,50
0.5, >10^ig/insect respectively for the co-treatment of the compound 
and the synergist piperonyl butoxide against the housefly, M.domestica.
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When perfused alone, diazepam and the two bicyclic compounds always 
failed to give any response. GABA did sonetimes give a small 
stimulation of release of radioactivity on its own when added at high 
concentrations, but this result was not readily reproducible. When 
the response was obtained, it was antagonised by PTX in a manner 
similar to the antagonism of the ivermectin response. Thus, although 
GABA would seem capable of producing a stimulation of release of 
radioactivity in this system, its low intrinsic activity explains why 
no enhancement of the ivermectin response was seen on cotreatment. 
Further, as the GABA response does not seem to be always present, in 
contrast to the ivermectin response which is, it would seem that, 
although GABA and ivermectin act in a similar manner at the GABA/Cl” 
channel complex in this system, they do so at different receptor 
sites - the one for GABA being highly labile in the extraction 
procedures used in this investigation.
The presence and metabolism of GABA in Insect nervous
Having shown the presence of a putative GABA neuroreceptor , to help 
to confirm that these are pharmacologically relevant it is necessary 
to show the presence of the amino acid itself and that of the enzymes 
for its production and degradation.
A.3.1 The levels of GABA present in the CNS of P.amerlcana
f i
The control level of GABA (XVII) in the CNS of the roach of 
1.61nmoles/mg protein works out to be approximately 12pmoles/g wet 
weight. This compares well with other values for the levels of GABA 
found in the insect CNS - e.g. 10-13pmole/g wet weight found in the 
cockroach by Pandey and Singh (1985) and the values given for the 
locust by Breer and Heilgenberg (1985) of between
10.7 and 21.5pmoles/g wet weight (dependent upon the region of the 
CNS assayed). Although these levels are higher than those found in 
the human brain where levels of 5.32pmoles/g wet weight have been 
quoted (Quastel: 1985), they are of the same order of magnitude. The 
fact that these levels were raised by the GABA-T inhibitors /-vinyl- 
and y-acetylenic-GABA (XXXIX and XL) helps to confirm that these 
levels are pharmacologically relevant and not merely extraction 
artifacts.
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A.3.2. The activities of the enzymes concerned with the production 
and degradation of GABA in the CNS of P.americana.
The metabolising enzymes for GABA were also found in the CNS of the 
cockroach. The GABA producing enzyme, GAD, was studied in slightly 
greater detail, as in the mammalian system this enzyme is taken as 
the key one in GABA metabolism and is widely used as a marker for 
GABA-ergic neurones (Saito et al.t 197A).
A.3.2.1 The activity of GAD
The K value for GAD obtained in this study compares well with those m
obtained by Breer and Heilgenberg (1985). At 12mM it is slightly 
less than the value they obtained for the roach (28mM) but is the 
same as that obtained for the locust. The of
125pmoles/min/mg wet weight is much lower than the values obtained by 
these two, which were 12.5nmoles/min/mg wet weight for the locust and 
lOnmoles/min mg wet weight for the cockroach. However, both these 
values are far higher than that found by Pandey and Singh (1985), who 
quote a GAD activity of only O.A pmoles/min/mg wet weight. In 
mammals values of around 150pmoles/min/mg wet weight have been found 
in the rat. This was the figure quoted by White (1981) in the paper 
which was basis for the procedure used in this study.
As with Breer and Heilgenberg, the current study indicated that there 
were two pH optima for the activity of GAD. Both studies showed one 
optimum to be close to pH 7 (6.9 in the current study, 7.1 in that 
undertaken by Breer and Heilgenberg: 1985), but there is a marked 
difference in the value for the second optimum. The German workers 
found this to be at pH 6.3 whilst this study Indicates an optimum in 
the region of pH 7.6-pH 7.8. In mammals a single optimum is found 
around pH 7, White (1981) quoting a value of 6.8 in rat brain.
The other characteristics of this enzyme are as expected.
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A.3.2.2 The activity of GABA-T
The activity for GABA-T in the roach CNS was found to be 
1 7 .1 pmoles/min/mg wet weight tissue. Again this is lower than the 
value found by Breer and Heilgenberg (1985) in their study, but the 
ratio of GAD activity to GABA-T activity of roughly 10:1 is similar 
in both cases. This is in contrast to the situation found by Pandey 
and Singh (1985), who found the level of GABA-T activity to be some 
lOOOx higher than that of GAD, which would also be the order of 
activity expected in mammalian tissues. This level is said to ensure 
the close control of GABA levels through the activity of GAD.
However, even with the reverse levels of activity found in this 
study, there should be no problems in the control of GABA levels in 
the CNS of the roach because of the comparmentalisation of production 
and degradation within the CNS. Most models propose presynaptic 
production of GABA prior to release, followed by removal from the 
synaptic cleft by high activity uptake into the glial cells and 
degradation by GABA-T (eg. Turner and Whittle: 1983).
A.A Conclusions
The aim of the study was the biochemical identification of receptors 
for L-glu (I) and GABA (XVII) in the CNS of the American cockroach, 
P.americana. After receptors relevant to the transmitter function of 
these two amino acids had been shown, the preparations could be used 
as tools to develop novel insecticides which would act through the 
modification of the neurotransmitter function of these two amino 
acids. How well were these objectives achieved?
A.A.1 The receptor for L-glu
e Í
The studies carried out in this thesis have shown the presence of 
radioligand binding sites for L-glu. The characteristics of these 
sites can be compared with the criteria for the acceptemce for 
receptor sites as physiologically relevant laid down in the 
introduction:
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a) Saturabillty: Saturable, Na ion concentration independent binding 
sites for
L-glu were clearly demonstrated, thus fulfilling the first of 
the criteria for the identification of a physiologically 
relevant receptor site.
b) Kinetics: Although detailed studies of the kinetics of the
receptors were not carried out, the equilibrium dissociation 
constant and receptor concentration were well within the 
ranges expected for a neuroreceptor site and were similar to 
those described by previous workers.
c) Distribution: The fact that such receptors were found in the CNS
of P.americana is one of the first pieces of evidence that 
L-glu may be acting centrally as well as peripherally in the 
insect nervous system. However, the failure to find these 
sites in the muscle preparations used was not as expected 
from the work of others in the field. This could well have 
been caused by the use of muscular tissue with less 
innervation than that normally used for such studies.
d) Pharmacology: The sites described in this study show a similiar
pharmacological profile to putative neuroreceptor sites 
described by workers in both the insect and mammalian fields, 
although it would appear that there are some fine differences 
between that of the mammalian and insect receptors. However, 
such sites do not fit easily into any of the major excitatory 
amino acid receptor types as defined by electrophysiological 
studies, either in the insects or in the mammalian systems. 
This may well be a consequence of the grossly differing 
environments used in the two types of study.
If these sites prove to be relevant to the role of L-glu as a 
neurotransmitter, this will be one of the first firm pieces of 
evidence that this amino acid works as such in the CNS of an insect 
species and it will indicate that there are differences between the 
mammalian and insect systems at this level that may be exploited in 
the design of a novel, safe insecticide.
A.A.2 The GABA/Cl“ channel complex.
Electrophyslological evidence has already shown that GABA is active 
in the insect CNS, so that any GABA receptors that were revealed by 
these studies would be the more readily accepted as relevant to the 
role of this amino acid as a neurotransmitter. Ccxnparing the results 
of these studies with the criteria in the introduction, the following 
conclusions can be drawn:
a) Saturability: The discovery of a saturable, Na'*' ion
concentration independent site for this ligand was to be 
expected and so the first criterion was met.
b) Kinetics: Once more the kinetics were not studied in detail. The
equilibrium values of the site studied in this report did not 
align well with those described elsewhere. However, other 
details of the results of this study suggest that this is a 
neuroreceptor site, so that the mismatch in this area was 
probably due to different preparation procedures.
c) Distribution: Once more, the type of membrane preparation used in
the main studies would be expected to show GABA neuroreceptor 
binding if such were present in the CNS. The failure to show 
such receptors in the muscle preparation is probably due to 
reasons similar to those described for the L-glu receptor, 
although the evidence for a GABA receptor in the insect 
muscle has always been more equivocal than for the L-glu 
receptor.
d) Pharmacology: This receptor is clearly not a transport site - as
shown by the lack of activity for the specific GABA transport 
blocker nipecotic acid (XXVI); and the profile of drugs able 
to displace radlolabelled muscimol (XXI) from the site is 
much as would be expected of a mammalian GABA^ receptor.
Although the failure of receptor binding studies to show the presence 
of the binding of the recognised Cl” channel receptors was 
disappointing, the results using the synaptosomal release system 
clearly show that the CNS of the cockroach contains Cl” channels that
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can be activated by the putative GABA-mimetic ivermectin. These Cl 
channels are blocked by the standard Cl" channel inhibitors, but the 
results using GABA in this system suggest that they may not be that 
closely linked with the GABA receptor shown in the ligand binding 
studies.
Finally the presence of GABA and the related metabolic enzymes in the 
CNS at levels that would be expected for there to be a transmitter 
role for this compound lends further support to the identification of 
the site described above as being relevant to the neurotransmitter 
activity of GABA in the CNS of insects.
A.A.3 The use of these sites as simple screens in the development 
of new insecticides.
One aim of this project was met, in that receptor sites for L-glu and 
GABA have been identified and shown to be relevant to the role of 
those two amino acids as neurotransmitter substances in the CNS of an 
insect species. However, the second role of the project, the 
development of a high throughput screen for the testing of putative 
insecticides, has not been fulfilled. For although these 
preparations can discriminate between the activity of various 
compounds at the receptor sites, the length of the procedures, the 
small amount of material obtainable from the insects and the large 
variability in the amount of radioactivity bound preclude the use of 
these membranes as a high throughput screen with the current ligands. 
For further progress to be made, both in the use of this type of 
preparation in the screening of insecticides interacting with the 
L-glu or GABA receptor sites on a potential target species and in the 
further typing of the two receptor sites, ligands of much higher 
affinity will have to be found, ones on a par with BTX at the 
nicotinic acetyl-choline receptor.
Perhaps such a ligand for the L-glu receptor will be provided by one 
of the venoms now being tested (eg. the toxin from the wasp 
Philanthus trlangulum, Clark et al.; 1982j the venom from the spider 
Nephila clavata, Yoshioka et al.: 1985). For the study of the 
GABA/Cl” channel site one of the bicyclooctane compounds recently . 
produced by Casida and his team may prove useful in the study of the
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Cl’ ionophore. The results with the synaptosomes have shown one of 
these compounds - TBOB (XLVII) - to be active at this site in the 
insect CNS. This group of compounds is highly insecticidal, with 
many expounds giving much higher kill in the housefly M,domestics 
than TBOB. The cyano-derivative of TBOB (XLIX), has a toxicity to 
the flies that is lOOx that of TBOB itself (Casida and Palmer: 1985) 
and can be readily tritiated. These factors make it a prime compound 
for use in such studies.
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